Catalog Advanced Search

Search by Category
Search by Format
Sort By
Search by Type
Search by Keyword
Search by Category
Search in Packages
Search by Format
Search by Type
Search by Date Range
Products are filtered by different dates, depending on the combination of live and on-demand components that they contain, and on whether any live components are over or not.
Start
End
Search by Keyword
Sort By
  • Contains 4 Component(s) Includes a Live Web Event on 08/13/2024 at 12:00 PM (EDT)

    Methamphetamines

    Methamphetamines

    Presenter: Petros Levounis, MD, MA, Professor and Chair, Department of Psychiatry, and Associate Dean, Rutgers New Jersey Medical School, Newark, NJ

    Learning Objectives

    • To be announced

    About The Series: ACMT's Grand Rounds offer an in-depth and interactive platform for learning and discussion about issues that impact the research and practice of medical toxicology. Experts from within and outside medical toxicology will share their knowledge and experience and highlight areas for collaboration and mutual understanding.

    This webinar is for ACMT members only.

    Petros Levounis, MD, MA

    Professor and Chair, Department of Psychiatry, and Associate Dean

    Rutgers New Jersey Medical School

    Petros Levounis, MD, MA, serves as professor and chair of the Department of Psychiatry and associate dean at Rutgers New Jersey Medical School. He is also the chief of service at University Hospital in Newark, New Jersey, director of the Northern New Jersey Medications for Addiction Treatment Center of Excellence, and president of the American Psychiatric Association. 

    Dr. Levounis completed his undergraduate work at Stanford University where he studied chemistry and biophysics before receiving his medical education at Stanford University School of Medicine and the Medical College of Pennsylvania. During medical school, he researched the effects of social class on patient-physician relationships in Oxford, England, and received an MA degree in sociology from Stanford. He then graduated from the Columbia University Psychiatry Residency program earning the National Institute of Mental Health Outstanding Resident Award and went on to complete his fellowship in addiction psychiatry at New York University.

    Dr. Levounis has published fourteen books including the self-help paperback “Sober Siblings: How to Help Your Alcoholic Brother or Sister—and Not Lose Yourself” and the textbook of “Substance Dependence and Co Occurring Psychiatric Disorders.” His books have been translated into French, German, Hungarian, Japanese, Korean, Portuguese, and Spanish.

  • Contains 46 Component(s), Includes Credits Includes Multiple Live Events. The next is on 06/14/2024 at 12:00 PM (EDT)

    On-Demand Prep Course for MedTox Certification Exam

    2024 ACMT Board Review Course

    The 2024 ACMT Board Review Course is back with an innovative twist for your learning experience! This online course is designed to prepare all examinees for the biennial certification examination in Medical Toxicology administered by the American Board of Emergency Medicine (ABEM). Led by prominent experts in the field of medical toxicology, you will receive a broad overview of the scope of the specialty and a detailed perspective into current clinical and public health toxicological issues.

    Register today! Access to course content begins: June 1, 2024

    Learner Objectives:

    1. Identify and review core topic areas in the specialty of Medical Toxicology.
    2. Prepare for common test questions and terms that may be found on a Medical Toxicology certification exam.
    3. Discuss initial management and standard treatment approaches of patients with toxicologic issues. 


    The Flipped Classroom Advantage

    Get prepared for the ABEM certification exam with our new Flipped Classroom format - the ultimate fusion of convenience, flexibility, and interactivity. In a departure from conventional learning approaches, our Flipped Classroom (a blended learning format) will give you access to a comprehensive array of 30+ meticulously curated on-demand lectures encompassing the entire spectrum of medical toxicology. This enriched content will be at your disposal June 1, 2024 - May 31, 2025, empowering you to proceed with your studies at a pace that aligns with your commitments.

    Interactive Cram Sessions

    In addition to the autonomous learning, prepare to be part of 7 live, interactive cram sessions throughout the summer and early fall. Focused on 4-5 core topics during each session, these power-packed sessions are your golden ticket to in-depth insights, key takeaways, and invaluable Q&A with our experts.

    Unparalleled Lectures

    Our top-notch speakers are ready to guide you through each lecture, ensuring you grasp every critical concept. These lectures are pre-recorded so you can access them anytime, anywhere and as many times as you want until you are confident in each subject area. Immerse yourself in a learning journey with lectures that drill down into each aspect of the Medical Toxicology Core Content including:

    Alcohols & GlycolsDrugs of Abuse & Withdrawal
    Pediatric Toxicity
    Analytics & ForensicsEndocrine
    Pesticides
    Anesthetics, NMBs & Muscle RelaxantsEpidemiology & Population HealthPharmaco & Toxicokinetics
    AntimicrobialsGastroenterology
    Poisonous Plants
    Antipsychotics
    HematologyPsychotropics
    Aquatic ToxicityHerbals, Vitamins & Supplements
    Radiation
    CarcinogenesisHydrocarbons
    Reproductive & Developmental Tox
    Cardiovascular ToxinsInhalational Toxins & Asphyxiants
    Statistical Measures
    ChemotherapeuticsMetals & Metalloids
    Terrestrial Toxicity
    Classic Toxicology
    Miscellaneous Toxins
    The Toxic House
    Clinical Drug Testing & DiagnosticsMushrooms & Fungal ToxinsWarfare/Terrorism
    Dermatology & PathologyNeurotoxins & Anticonvulsants
    Study Resources 

    In addition to an on-demand library of medical toxicology core lectures, avail yourself of this courses additional study resources. Click here for more info!


    Questions?

    Please write to ACMT at events@acmt.net

    Registration Rates

    Registration CategoriesFees

    ACMT Members

    $1500

    Non-Members

    $1750


    Registration includes:

    • Access to the on-demand content: June 1, 2024 - May 31, 2025
    • Access to 7 interactive cram sessions - live Q&A with the speakers
    • Access to PDFs of the lecture slides & handouts
    • Access to Quiz Bank
    • Access to online Flashcards
    • Continuing Medical Education credits (~25.0)



    ACMT Membership

    ACMT Members receive a discounted rate. Interested in becoming an ACMT Member? Contact our Membership Manager at membership@acmt.net. Learn more at: www.acmt.net/membership


    Continuing Education

    Enduring Continuing Medical Education (CME) credit for this activity is included in the registration fee (at no additional cost).


    Print Materials

    Prefer to study with hardcopies? Print slide books and print flashcards are available for purchase. Click on the buttons below for more info:

    Print Slide Book     Print Flashcards


    Cancellation Policy

    Cancellations made on or before May 16, 2024 will receive a full refund less an 8% processing fee. Cancellations made after this date will not receive a refund. Limited exceptions may be considered for emergency situations pending review.

    All cancellation requests must be made in writing and emailed to: events@acmt.net. No telephone cancellations will be accepted. A refund that results from a cancellation or change to your registration will be returned to the original payer and in the original method of payment.

    Pending review, limited exceptions will be made based on need and circumstance and must be submitted in writing to events@acmt.net. Because each exception must undergo a review and approval process, we ask in advance for your patience.

    Click here to read ACMT's full cancellation policy.


    Questions?

    Write to: events@acmt.net

    Study Resources

    When you register for this course, we'll arm you with an arsenal of study resources. Dive into the Quiz Bank to put your knowledge to the test, flip through flashcards for rapid-fire revision, and explore visual stimuli to enhance your understanding. The ACMT Board Review Course includes:

    Study Materials: slides, handouts, and supplementary materials 
    Flashcards: 350+ flashcards to help you study keywords and concepts
    Quiz Bank: 800+ practice questions and answers, quizzes on a variety of toxicological issues to help you prepare for certification


    Print Material Add-Ons

    Prefer studying with hardcopies? For an additional fee, we have print versions of the Study Materials and Flashcards that we can ship directly to your home or office.

    Purchase Print Slide Book     Purchase Print Flashcards

    Continuing Education

    image

    Continuing Education credit for this activity is pending and will be provided by AKH Inc., Advancing Knowledge in Healthcare. 

    Physicians
    Pending review of content and faculty disclosures, it is estimated that AKH Inc., Advancing Knowledge in Healthcare will designate this enduring material for around 25.0 AMA PRA Category 1 Credit(s)™. The exact number of credits will be ascertained after collection of all enduring material from faculty in May 2024.


    Concerns or complaints about a CE provider may be directed to the provider, or to the Commission for Continuing Education Provider Recognition at ADA.org/CERP.

    Ann Arens, MD

    Emergency Medicine Physician

    Ochsner Medical Center

    Dr. Arens is an Emergency Medicine physician who practices at Ochsner Medical Center in New Orleans, LA. Dr. Arens completed her Emergency Medicine training at the Denver Health Residency in Emergency Medicine, and her medical toxicology training at the University of California – San Francisco. She was amongst the first toxicologists to identify and describe counterfeit fentanyl products, and has continued to identify outbreaks of new drugs of abuse. She has a broad range of research interests including: the identification of new drugs of abuse including novel opioids contributing to the current opioid epidemic, the use of antidotes, and advanced supportive care of the poisoned patient.

    Jeffrey Brent, MD, PhD, FACMT

    Distinguished Clinical Professor of Medicine (Pulmonary and Critical Care) and Emergency Medicine

    University of Colorado School of Medicine and Public Health

    Jeffrey Brent, M.D., Ph.D., is a Distinguished Clinical Professor of Medicine (Pulmonary and Critical Care Medicine) and Emergency Medicine at the University of Colorado Schools of Medicine and Public Health. He did his fellowship in medical toxicology at the Rocky Mountain Poison and Drug Center, where he has been both medical director and fellowship director. He is a former President of the American Academy of Clinical Toxicology and a former Board member of the American College of Medical Toxicology. Dr. Brent is the senior editor of Critical Care Toxicology: the Diagnosis and Management of the Critically Poisoned Patient, currently in its second edition. Dr. Brent is Co-Principal Investigator of ACMT’s Toxicology Investigators Consortium.

    Michele Burns, MD, FACMT

    Associate Physician

    Boston Children's Hospital

    Dr. Michele Burns is a pediatric emergency medicine physician in Boston, Massachusetts and is affiliated with multiple hospitals in that area, including Brigham and Women's Hospital and Boston Children's Hospital. She received her medical degree from Emory University School of Medicine and has been in practice for more than 20 years.

    Shaun D. Carstairs, MD, FACMT

    Medical Toxicologist

    98point6, Inc.

    Dr. Carstairs earned his undergraduate degree from the California Institute of Technology in Pasadena, CA and received his medical degree from the Uniformed Services University of the Health Sciences (USU), the nation's military medical school.  He completed a residency in emergency medicine at the Naval Medical Center in San Diego and a fellowship in medical toxicology at the University of California, San Diego.  He served more than 25 years on active duty in the U.S. Navy, which included a combat deployment to Iraq and shipboard deployment as the leader of a mobile trauma team for the Navy’s Pacific Fleet. He retired from the Navy as a Captain in 2019. He currently serves as a faculty member in the Department of Emergency Medicine & Division of Medical Toxicology at the University of California, San Diego (UCSD). In addition to his role at UCSD, he holds an appointment as Professor of Military & Emergency Medicine at USU.

    Leslie R. Dye, MD, FACMT, FASAM, FACCT

    Interim Medical Director, OneFifteen

    Clinical Professor, Wright State University/Boonshoft School of Medicine

    Leslie R. Dye, MD is triple board certified in emergency medicine, medical toxicology, and addiction medicine. She has worked in the fields of medical toxicology and addiction medicine for 30 years. In addition to her clinical expertise, she has academic and business content expertise from experiences as an editor-in-chief (EIC) of a peer-reviewed medical journal (Journal of Medical Toxicology) and EIC of physician and pharmacist content production for a leading international medical digital content provider. Her deep subject matter expertise is demonstrated in her role as senior editor of the textbook, Case Studies in Medical Toxicology, author of 18 peer reviewed publications and 16 textbook chapters, 66 national and 11 international presentations, 10 various commentaries, interviews, and podcasts. Her leadership skills have been proven in both corporate and academic environments, as professor at a medical school, long-term board member and past president of the American College of Medical Toxicology, Chair of the Addiction Medicine Committee, former co-chair, and co-moderator of the AACT Acute and Intensive Care Symposium, and as the manager of as many as 30 team members at an international corporation. She received a funded grant that enabled her to start the first poison control center in mainland China and trained 6 Chinese physicians in the field of medical toxicology over 3 years in the US. Dr. Dye is experienced in and continues to provide medical care in remote polar regions with no access to advanced medical facilities.

    Christina Hantsch, MD, FACEP, FAACT, FACMT

    Emergency Physician and Medical Toxicologist

    Dr. Hantsch is a graduate of the Honors Program in Medical Education at Northwestern University. She completed an emergency medicine residency, including a year as chief resident, at the Medical College of Wisconsin and then continued her training in a medical toxicology fellowship at Vanderbilt University. After her fellowship, she spent nearly 22 years at Loyola University Chicago Stritch School of Medicine and Loyola University Medical Center. There, she established an inpatient toxicology clinical service and clinical rotations for graduate medical trainees and students in multiple fields. With an interest in medication management and safety, she joined the hospital Pharmacy and Therapeutics Committee, serving as member for 6 years before being appointed chair and leading the committee for another 6 years. Dr. Hantsch earned the academic rank of Professor of Emergency Medicine, was Director of the Division of Toxicology, and Director of Academic Affairs in the Department of Emergency Medicine. As a clinical faculty member, she was appointed to the Stritch Committee on Academic Rank and Tenure, serving for 7 years including 2 as a subcommittee chair leading revision of the clinician educator track guidelines. In 2018, she was the founding Program Director of the Loyola emergency medicine residency. Dr. Hantsch served for more than 8 years as Medical Director of the Illinois Poison Center. In addition, she is a regular organizer and contributor to many local, regional, and national/international continuing education programs. After leaving academics, she worked for the U.S. FDA in pharmacovigilance for a year. As of 2022, she is board certified in addiction medicine in addition to emergency medicine and medical toxicology. Dr. Hantsch was elected to the ACMT Board of Directors in 2021, is a member of the Education Committee, and chair of the Practice Committee.

    Ashley Haynes, MD, FACEP

    Medical Toxicologist, Addiction Medicine Specialist

    Veterans Health Administration

    Dr. Haynes completed training in a combined emergency medicine-internal medicine program in 2014, and a toxicology fellowship at UTSW in 2016. She has been treating substance use disorders as part of her practice since that time and is board certified in addition medicine. She currently works for the VA at the Robert J Dole Veterans Medical Center in Wichita, KS, treating patients in a residential treatment center, as well as clinic, and performing bedside consults.

    Michael G. Holland, MD, FEAPCCT, FAACT, FACOEM, FACMT, FACEP

    Professor of Emergency Medicine

    SUNY Upstate Medical University

    Dr. Holland is Clinical Professor of Emergency Medicine at SUNY Upstate Medical University in Syracuse, NY where he is on the faculty of the Medical Toxicology Fellowship Training Program and is a Consulting Medical Toxicologist at the Upstate New York Poison Center and the Onondaga County Medical Examiner’s Office-both in Syracuse, NY. Dr. Holland is also the Director of Occupational Medicine for the Saratoga Hospital Medical Group, and is the Saratoga Hospital Employee Health Medical Director, where he oversees the health and safety of over 3100 employees and staff. He also serves as Employee Health Medical Director at Glens Falls Hospital in Glens Falls, NY, covering 2500 employees. He is also Principal Medical Toxicologist at the Center for Toxicology and Environmental Health (CTEH) in Little Rock, AR.    

    Ziad Kazzi, MD, FAAEM, FACEP, FACMT, FAACT

    Professor, Department of Emergency Medicine

    Emory University School of Medicine

    Born in 1975 and raised in Beirut, Lebanon, Dr. Kazzi trained in Emergency Medicine at Emory University in Atlanta (2000-03) where he served as a chief resident before completing a subspecialty fellowship in Medical Toxicology at Emory University, Georgia Poison Center and the Centers for Disease Control and Prevention (CDC) in Atlanta. He is board certified in both Emergency Medicine and Medical Toxicology. Dr. Kazzi joined the Department of Emergency Medicine at the University of Alabama at Birmingham (UAB) between 2005 and 2008 where he served as a Medical Toxicologist for the Regional Poison Control Center in Birmingham and the Alabama Poison Center. Currently, he is an associate professor at the department of Emergency Medicine at Emory University in Atlanta, Georgia as well as the director of the International Toxicology Postdoctoral Fellowship Program at Emory University (http://www.em.emory.edu/services/toxicology/international_postdoc_training.html). He is also the assistant medical director of the Georgia Poison Center (www.georgiapoisoncenter.org) and a medical toxicologist at the Radiation Studies Branch of the National Center for Environmental Health at the CDC (https://www.cdc.gov/nceh/radiation/) where he participates in emergency preparedness and response activities in radiation. As an emergency physician and toxicologist, Dr. Kazzi specializes in the recognition, triage, and management of poisonings and holds a deep interest in the areas of Radiation and International Toxicology. Over the past decade, he developed strong ties to India in the areas of medical toxicology, mass gathering medical preparedness, radiation emergency medicine, blast injuries and hazmat. Through his collaboration with the CDC, AIIMS, and PGIMER Chandigarh, he has delivered and co-directed the first Advanced Hazmat Life Support trainings in Ahmedabad and Delhi. He organized a number of training conferences in Nashik, Pune, Ujjain and Delhi and has been an invited speaker at the annual INDUS EM world congress. He is an active and founding board member of the Middle East North Africa Toxicology Association (www.menatox.org) and currently serves as its President. He is also a board member and chairs the International Committee of the American College of Medical Toxicology (www.acmt.net).

    William "Russ" Kerns, II, MD, FACMT, FACEP

    Emeritus Professor of Emergency Medicine

    Carolinas Medical Center

    Dr. Kerns trained in Emergency Medicine and Medical Toxicology and served as Professor in both disciplines at Carolinas Medical Center for 33 years. Faculty roles included leadership of the Medical Toxicology Fellowship and clinical division, consultation for the Carolinas Poison Center, and research. Research interests included antidotes, envenomation, and resuscitation of cardiotoxic drugs. He also served the ACMT focusing on advancing research and education.

    Joshua D. King, MD, FACMT

    Associate Professor, Medicine and Pharmacy; Medical Director, Maryland Poison Center

    University of Maryland School of Medicine

    Dr. King received his medical education from Penn State College of Medicine, and completed Internal Medicine residency and chief residency at the University of Virginia. He completed Nephrology fellowship at Johns Hopkins Hospital, and after returning to the University of Virginia as a nephrologist, completed a medical toxicology fellowship there. Dr. King is a clinician-educator nephrologist and medical toxicologist with clinical interests in extracorporeal treatment of poisonings, extracorporeal removal of therapeutic drugs, ICU nephrology, and medical education. As a clinician, he sees hospitalized patients at the University of Maryland Medical Center on our nephrology consultation service as well as our medical toxicology consult service. He is involved in education primarily at the graduate medical education level, and to a lesser extent undergraduate medical education. Dr. King is also the medical director of the Maryland Poison Center, which provides poisoning information and treatment recommendations benefitting thousands of Marylanders each year. Dr. King carries out medical oversight of recommendations for poisonings, envenomations, and overdoses to the public and health care providers; provides education to a variety of students (pharmacy and medical) and physicians (residents and fellows) who rotate with the center; he is involved in a variety of other activities aimed at treatment and prevention of poisoning. Dr. King's research interests are largely focused where nephrology and toxicology meet – extracorporeal removal of toxins (via dialysis, apheresis, and other modalities).

    Kurt C. Kleinschmidt, MD, FACMT, FASAM

    Professor of Emergency Medicine

    University of Texas Southwestern Medical Center

    Kurt C. Kleinschmidt, MD, FACMT, FASAM is a Professor of Emergency Medicine at the University of Texas Southwestern Medical Center in Dallas, Texas. He is a faculty member in the Division of Medical Toxicology. His areas of interest include Substance Use Disorders and snake envenomations. He graduated from the University of South Florida College of Medicine in 1986, completed his emergency medicine residency at Madigan Army Medical Center in 1990, and finished a clinical fellowship in Medical Toxicology at the University of Texas Southwestern Medical Center in 1999. He is board certified in Emergency Medicine (1991), Medical Toxicology (2002), and Addiction Medicine (2016). He became the Medical Director of the Perinatal Intervention Program in Parkland Health and Hospital system in 2016. He served as the Toxicology Program Director from 2004-2018 and as the Toxicology Division Chief from 2004-2020.

    Vincent R. Lee, MD (Moderator)

    Assistant Professor

    Donald and Barbara Zucker School of Medicine at Hofstra/Northwell

    Dr. Lee is an emergency medicine physician at Glen Cove Hospital and medical toxicology attending for Northwell Health. He received his medical degree from SUNY Downstate in Brooklyn, NY, in 2015, completed his emergency medicine residency at Morristown Medical Center in Morristown, NJ, in 2018, and his Medical Toxicology Fellowship at Northwell Health in Long Island, NY, in 2020. He is board-certified in emergency medicine and medical toxicology. 

    Michael Levine, MD, FACMT (Moderator)

    Associate Professor of Emergency Medicine

    University of California, Los Angeles

    Michael Levine is a Los Angeles native, who completed his emergency medicine residency at the Harvard Affiliated Emergency Medicine program, based out of Brigham and Women’s Hospital and Massachusetts General Hospital. After residency, he completed his medical toxicology fellowship at Banner Good Samaritan Medical Center in Phoenix, AZ. After staying as faculty for a year in Phoenix, he moved back to Los Angeles, where he joined the faculty at USC. He is currently the division chief of medical toxicology. He is actively involved in patient care, research, and serves on numerous hospital and university committees. He is an active member of American College of Emergency Physicians, the American College of Medical Toxicology, and is a member of the Toxicology Investigator's Consortium.

    Nima Maljesi, DO

    Director of Medical Toxicology

    Staten Island University Hospital Emergency Department

    Dr. Nima Majlesi completed Emergency Medicine Residency at Morristown Medical center in Morristown, NJ, in 2007, and went on to complete fellowship in medical toxicology at Northshore University hospital (now Northshore University hospital at Northwell) in Manhasset, NY, in 2009. Dr. Majlesi is board certified in Emergency medicine, medical toxicology and addiction medicine. In addition to initiating a 24/7 medical toxicology consultation service, he is the chair of the hospital pharmacy and therapeutics committee and helped initiate a program to initiate buprenorphine in the emergency department. He has been involved in creating guidelines regarding opioid prescribing for New York City, National emergency medicine organizations as well as his own institution. Education has been the main focus of his career.

    Christopher W. Meaden, MD, MS, FAAEM (Moderator)

    Assistant Professor of Emergency Medicine

    Rutgers New Jersey Medical School

    Dr. Christopher Meaden is Assistant Professor of Emergency Medicine at Rutgers New Jersey Medical School and a Medical Toxicology Consultant for the New Jersey Poison Information and Education System. He completed his residency training in emergency medicine at St. Joseph’s University Medical Center in Paterson, NJ and completed his medical toxicology fellowship as the inaugural fellow at Rutgers New Jersey Medical School. He is board certified in emergency medicine and medical toxicology. Dr. Meaden has a Master of Science degree in molecular and cellular biology. His interests include education in medical toxicology, acute care of the poisoned patient and chemical agents of war. He is involved with the American College of Medical Toxicology Education Committee and previously served as the associate chair for the 2022 and 2023 ACMT Annual Scientific Meeting. 

    Charles McKay, MD, FACMT

    Associate Medical Director

    CT Poison Control Center, University of Connecticut School of Medicine

    Dr. McKay was trained in Anatomic and Surgical Pathology, Internal Medicine, Emergency Medicine, Medical Toxicology and was a Medical Director of Occupational Health and Medical Review Officer for a hospital system during more than 30 years of clinical practice, during which he provided toxicology consultation at 3 hospitals, directed a medical toxicology fellowship training program, and provided medical oversight of a regional poison control center. He provides medical legal consultation across the country on toxicology-related issues, and has testified in nearly 100 cases, many related to questions of alcohol- and -drug-induced impairment.

    Joshua Nogar, MD

    Director of Medical Toxicology, Medical Toxicology Fellowship Director

    Hofstra/Northwell Health

    Dr. Josh Nogar grew up in the High Desert of New Mexico, but has been a New Yorker for 16 years. Dr. Nogar received his medical degree from the New York University School of Medicine in 2005, completed a residency in Emergency Medicine at the University of New Mexico in 2009, and a fellowship in Medical Toxicology at the University of California San Diego in 2011. He has been faculty in the department of Emergency Medicine & Medical Toxicology at North Shore University Hospital since 2011, in Long Island, NY. He has been the Medical Toxicology Fellowship Director at Northwell Health since 2016, and his areas of specific interest include fellow education, metabolic uncouplers, overdose trends, and addiction medicine. He is dedicated to helping trainees achieve their individual career goals, as well as adapting his training program to the changing scope of practice for Medical Toxicologists, as well as the needs to individual learners. Outside of work, Dr. Nogar enjoys spending time with his wife & children. He is an avid fly-fisherman.

    J.J. Rasimas, MD, PhD, FAACT, FACLP, FACMT, FACPsych

    Professor of Psychiatry & Emergency Medicine

    University of Minnesota & Penn State College of Medicine

    Dr. Rasimas attended the University of Scranton and graduated summa cum laude with degrees in biochemistry, mathematics, and philosophy. He completed the Medical Scientist Training Program at Penn State University, earning a Ph.D. in chemical biology (2002) and M.D. (2003). Upon graduation from the Penn State College of Medicine, Dr. Rasimas matriculated to psychiatry residency training at the Mayo Clinic in Rochester, Minnesota. He was a clinical fellow at the NIMH, training in consultation-liaison psychiatry, bioethics, and clinical research. Dr. Rasimas has studied psychoanalytic psychotherapy at the Minnesota Psychoanalytic Society and Institute and the Washington School of Psychiatry. He served as a C-L psychiatrist for Milton S. Hershey Medical Center and remains an Associate Professor of Psychiatry and Emergency Medicine for the Penn State College of Medicine, there. He completed the critical care based medical toxicology fellowship at Penn State, obtained board certification in addiction medicine, and then returned to NIMH to join the Undiagnosed Diseases Program and the Intramural Research Program to oversee clinical trials in mood and anxiety disorders. He is also a Fellow of the Academy of Psychosomatic Medicine and a Laughlin Fellow with membership in the American College of Psychiatrists. Dr. Rasimas is a Professor at the University of Minnesota, pursuing an academic medical career at the interface of psychosomatic medicine, medical toxicology, and psychodynamic psychotherapy with a primary clinical interest in the phenomenology of suicide. His current clinical position is the director of Consultation-Liaison Psychiatry services for the Queen Elizabeth Hospital in Charlottetown, Prince Edward Island.

    Daniel J. Sessions, MD

    Medical Toxicologist

    Ochsner Medical Center

    Dr. Sessions trained in Emergency Medicine at Brooke Army Medical Center in San Antonio. He completed a Medical Toxicology fellowship at The Rocky Mountain Poison & Drug Center at Denver Health. He practices Emergency Medicine, Medical Toxicology, and Addiction Medicine at Ochsner Medical Center in New Orleans LA. He is also faculty at the Minnesota Poison Center.

    Sarah Shafer, MD

    Assistant Professor of Emergency Medicine and Medical Toxicology

    University of Iowa Department of Emergency Medicine

    Sarah Shafer, MD, is an assistant professor of emergency medicine and medical toxicology at University of Iowa Department of Emergency Medicine in Iowa City. You may know her through her twitter handle @toxiferoustales.

    Jerry W. Snow, MD

    Associate Professor of Emergency & Internal Medicine

    Banner – University Medical Center Phoenix

    Dr. Jerry Snow serves as the Program Director for the Medical Toxicology Fellowship and holds the position of Associate Professor in both Emergency Medicine and Internal Medicine at Banner – University Medical Center Phoenix. Actively engaged, he contributes to key committees such as the Banner Critical Care Committee, Banner Behavioral Health Clinical Consensus Group, Department of Medical Toxicology Clinical Competency Committee, and the Addiction Medicine Section. Nationally, Dr. Snow is involved with the ACMT Education Committee, actively participating in the Board Review Course.

    Alaina R. Steck, MD, FACMT, FASAM (Moderator)

    Associate Professor of Emergency Medicine

    Emory University

    Dr. Alaina Steck is an Associate Professor of Emergency Medicine in the Emory School of Medicine and the Medical Director of Grady Memorial Hospital's oupatient OUD treatment clinic. She is board-certified in Emergency Medicine, Medical Toxicology, and Addiction Medicine, and actively practices all three specialties at Grady Memorial Hospital in Atlanta. She is on the advisory boards of the Christopher White Crusade and YourPath Health. Her research and clinical efforts focus on transitions of care from the Emergency Department, integration of Addiction Medicine care with other specialty services (e.g., Orthopedics, Trauma Surgery, and Infectious Diseases), and the impact of OUD treatment on health care utilization.

    Samuel J. Stelpflug, MD, FACMT

    Director, Twin Cities Medical Toxicology Fellowship

    University of Minnesota Medical School

    Dr. Stellpflug is the Director of the Regions Hospital Clinical Toxicology Service (Saint Paul, MN) and the Twin Cities Med Tox Fellowship. He also practices, teaches, and learns as a faculty physician in the Regions Department of Emergency Medicine. He provides consultation for the Minnesota Poison Control System, and his academic appointment is through the University of Minnesota Medical School. Following medical school at the University of Wisconsin he completed a residency in emergency medicine at Regions Hospital and then the medical toxicology fellowship in the Twin Cities, a joint effort between the Regions Hospital / HealthPartners and the Minnesota Poison Control System. Dr. Stellpflug’s research interest is in treatment of poison-induced cardiogenic shock, among other things.

    Joshua Trebach, MD (Moderator)

    Emergency Medicine Physician & Medical Toxicologist

    University of Iowa Hospitals and Clinics

    Josh Trebach is an emergency medicine physician and medical toxicologist at the University of Iowa Hospital and Clinics. He completed his undergraduate training at Virginia Tech, medical school training and residency at Johns Hopkins, and toxicology fellowship at New York University/New York City Poison Control Center. Josh is currently the Director of Resident Medical Toxicology Education at the University of Iowa and is passionate about all things toxicology, medical education, social media, LGBTQ health, and animal rescue.

    Stephanie Weiss, MD, PhD

    Staff Clinician, Translational Addiction Medicine Branch

    National Institute on Drug Abuse

    Dr. Stephanie Weiss is the Staff Research Physician serving the Translational Addiction Medicine Branch of the National Institute on Drug Abuse’s Intramural Research Program. After earning a Ph.D. in pharmaceutical chemistry, Dr. Weiss received her medical degree in 2011.  She is board certified in emergency medicine, addiction medicine, and medical toxicology and was selected to participate in the Boston University Research in Addiction Medicine Scholars Program prior to joining NIDA.  Dr. Weiss is responsible for providing optimal, safe, and ethical care to study participants and clinical support toward the TAMB mission conducting inpatient and outpatient proof-of-concept human laboratory studies. Her research interests include novel psychoactive substances, medication misuse, and improving interpretation of urine drug testing.

    Interactive Cram Sessions


    Interactive Cram Session #1

    Friday, June 14, 2024, 12:00-1:00 PM ET

    • Pharmacokinetics & Toxicokinetics
    • Neurotoxins & Anticonvulsants
    • Pediatric Toxicity
    • Anesthetics, NMBs & Muscle Relaxants
    • Analytics & Forensics

    Interactive Cram Session #2

    Friday, June 28, 2024, 12:00-1:00 PM ET

    • The Toxic House
    • Poisonous Plants
    • Warfare/Terrorism
    • Chemotherapeutics
    • Pesticides

    Interactive Cram Session #3

    Friday, July 12, 2024, 12:00-1:00 PM ET

    • Hydrocarbons
    • Alcohols & Glycols
    • Aquatic Toxicity
    • Radiation
    • Cardiovascular Toxins

    Interactive Cram Session #4

    Friday, July 26, 2024, 12:00-1:00 PM ET

    • Classic Toxicology
    • Antipsychotics
    • Psychotropics
    • Endocrine
    • Metals & Metalloids

    Interactive Cram Session #5

    Friday, August 9, 2024, 12:00-1:00 PM ET

    • Inhalational Toxins & Asphyxiants
    • Carcinogenesis
    • Reproductive & Developmental Tox
    • Epidemiology & Population Health
    • Statistical Measures

    Interactive Cram Session #6

    Friday, August 23, 2024, 12:00-1:00 PM ET

    • Herbals, Vitamins & Supplements
    • Terrestrial Toxicity
    • Hematology
    • Immunologics
    • Nervous System
    • Antimicrobials

    Interactive Cram Session #7

    Friday, September 6, 2024, 12:00-1:00 PM ET

    • Gastroenterology
    • Mushrooms & Fungal Toxins
    • Drugs of Abuse & Withdrawal
    • Clinical Drug Testing & Diagnostics
    • Dermatology & Pathology
    • Miscellaneous Toxins
    • Register
      • Non-member - Tier I - $1,750
      • Non-member - Tier II - $1,750
      • Non-member - Tier III - $1,750
      • Non-member - Tier IV - $1,750
      • Member - Tier I - $1,500
      • Member - Tier II - $1,500
      • Member - Tier III - $1,500
      • Member - Tier IV - $1,500
    • More Information
  • Contains 4 Component(s) Includes a Live Web Event on 06/11/2024 at 12:00 PM (EDT)

    Alphabet Soup of Regulatory Toxicology

    Alphabet Soup of Regulatory Toxicology

    Presenter: Michael Holland, MD, FACMT, FAACT, FEACCT, FACOEM, FACEP, SUNY Upstate Medical University, Syracuse, NY

    Learning Objectives

    • To be announced

    About The Series: ACMT's Grand Rounds offer an in-depth and interactive platform for learning and discussion about issues that impact the research and practice of medical toxicology. Experts from within and outside medical toxicology will share their knowledge and experience and highlight areas for collaboration and mutual understanding.

    This webinar is for ACMT members only.

    Michael G. Holland, MD, FEAPCCT, FAACT, FACOEM, FACMT, FACEP

    Professor of Emergency Medicine

    SUNY Upstate Medical University

    Dr. Holland is Clinical Professor of Emergency Medicine at SUNY Upstate Medical University in Syracuse, NY where he is on the faculty of the Medical Toxicology Fellowship Training Program and is a Consulting Medical Toxicologist at the Upstate New York Poison Center and the Onondaga County Medical Examiner’s Office-both in Syracuse, NY. Dr. Holland is also the Director of Occupational Medicine for the Saratoga Hospital Medical Group, and is the Saratoga Hospital Employee Health Medical Director, where he oversees the health and safety of over 3100 employees and staff. He also serves as Employee Health Medical Director at Glens Falls Hospital in Glens Falls, NY, covering 2500 employees. He is also Principal Medical Toxicologist at the Center for Toxicology and Environmental Health (CTEH) in Little Rock, AR.    

  • Contains 4 Component(s) Includes a Live Web Event on 05/16/2024 at 1:00 PM (EDT)

    Cases to be Announced.

    NCC - 5/2024

    Cases to be Announced.


    Series Moderator: Lewis Nelson, MD, FACMT, Rutgers New Jersey Medical School, Newark, NJ

    About The Series: ACMT's National Case Conference (NCC) is a monthly webinar for ACMT members that features interesting cases seen by medical toxicologists nationwide. NCC is an educational endeavor and a quality improvement effort intended to improve patient care. It is not intended to define standard of care. Attempts have been made to ensure HIPAA compliance. All data and information provided in this activity is for informational purposes only. ACMT makes no representations as to accuracy, completeness, currentness, suitability, or validity of the content and will not be liable for any errors or omissions in this information or any losses, injuries, or damages arising from its display or use.

    This webinar is for ACMT members only.

    Lewis Nelson, MD, MBA, FACMT, FASAM

    Chair of Emergency Medicine

    Rutgers New Jersey Medical School

    Lewis S. Nelson, MD is Professor and Chair of the Department of Emergency Medicine at Rutgers New Jersey Medical School, Chief of Service for the Emergency Department at University Hospital of Newark, and Senior Consultant to the New Jersey Poison Information & Education System. Dr. Nelson is board certified in emergency medicine, medical toxicology, and addiction medicine. His areas of specific interest include preventing and managing the consequences of opioid and other substance use, multimodal pain management strategies, health policy, and medication safety.

    Dr. Nelson has served as President of American College of Medical Toxicology and on the Board of Directors of both the American Board of Emergency Medicine and the Accreditation Council for Continuing Medical Education. He is currently the president of Association of Academic Chairs in Emergency Medicine. He is a long time consultant for several governmental agencies including the Centers for Disease Control and Prevention, the Department of Homeland Security, and the Food and Drug Administration. He is an editor of the textbook “Goldfrank’s Toxicologic Emergencies.

  • Contains 4 Component(s) Includes a Live Web Event on 05/14/2024 at 12:00 PM (EDT)

    This month's articles will be reviewed by TBA

    Title TBA

    Tuesday, May 14, 2024
    12:00-1:00 PM ET

    Presented by:
    TBA

    Articles:

    • Coming soon!

    Series Moderator: Steven E. Aks, DO, FACEP, FACMT, Toxikon Consortium

    About The Series: ACMT's National Journal Club (NJC) is a bimonthly member webinar hosted by a different fellowship program each session. All data and information provided in this activity is for informational purposes only. ACMT makes no representations as to accuracy, completeness, currentness, suitability, or validity of the content and will not be liable for any errors or omissions in this information or any losses, injuries, or damages arising from its display or use.

    This webinar is for ACMT members only.

    Steven E. Aks, DO, FACMT (Moderator)

    Toxicology Director and Professor of Emergency Medicine

    Rush Medical College

    Dr. Steven Aks graduated from the New York Institute of Technology College of Osteopathic Medicine in 1987. He works in Chicago, IL and 4 other locations and specializes in Public Health & General Preventive Medicine, Emergency Medicine and Medical Toxicology. Dr. Aks is affiliated with John H Stroger Jr Hospital Of Cook County.

  • Contains 5 Component(s) Includes a Live Web Event on 05/03/2024 at 1:00 PM (EDT)

    ACMT/PCORI: Confronting the Overdose Epidemic by Engaging Patients to Improve Medical Toxicology Research

    ACMT/PCORI: Confronting the Overdose Epidemic by Engaging Patients to Improve Medical Toxicology Research

    Case 1: Aligning Medical Toxicology and Addiction Medicine Research from a Patient-Centered Perspective
    Case 2: Inclusion of Patient Experts into the Research Process

    Learner Objective: Describe the importance of including patient experts into the research process to ultimately improve medical toxicology and addiction medicine research and clinical practice. 


    About The Series: The ACMT/ASAM Addiction Toxicology Case Conference webinar series discusses Addiction/Toxicology cases in an interactive fashion featuring experts from Addiction Medicine, Addiction Psychiatry, and Medical Toxicology.

    This webinar is open to the public.

    Continuing Education credits are now available for this activity! Click here for more info.

    Timothy Wiegand, MD, DFASAM, FACMT, FAACT (Moderator)

    Director of Addiction Medicine and Addiction Medicine Consults

    University of Rochester Medical Center

    Timothy J. Wiegand, MD, FACMT, FAACT, DFASAM is an Associate Professor of Emergency Medicine and Public Health Sciences at the University of Rochester Medical Center in Rochester New York.  He is Board Certified in Medical Toxicology and Addiction Medicine and practices in Addiction Toxicology with a mix of clinical,  research, teaching, and other professional work.  Dr. Wiegand has served two terms on the Board of Directors for the American College of Medical Toxicology (ACMT) and he is currently serving on the Board of Directors for the American Society of Addiction Medicine (ASAM) completing a term on the Executive Counsel as Vice President of ASAM.  He begins a two-year term as Treasurer of ASAM in April 2023.  Dr. Wiegand founded and led the Toxicology service at URMC until 2022 when he became Director of Addiction Medicine and Director of Addiction Medicine Consults also at URMC in the Department of Emergency Medicine.  Dr. Wiegand has served as Fellowship Director for the URMC Combined Addiction Medicine Fellowship and he is the Fellowship Director for the URMC Medical Toxicology fellowship expecting to formally begin once accredited, in July of 2023.

    Gloria Baciewicz, MD (Moderator)

    Addiction Psycharcist

    Strong Recovery

    Since 1986, Gloria Baciewicz has specialized in the treatment of addiction. Professor of clinical psychiatry at the University of Rochester Medical Center, she serves as an addiction psychiatrist at Strong Recovery. Dr. Baciewicz is certified in addiction medicine by the American Board of Preventive Medicine and board certified in psychiatry, with added qualifications in addiction psychiatry. Dr. Baciewicz is a co-principal investigator for the University of Rochester’s Recovery Center of Excellence.

    Rachel Culbreth, PhD, MPH

    ToxIC Research Director

    American College of Medical Toxicology

    Dr. Culbreth joined the Toxicology Investigators Consortium/ACMT in May 2022. She received her PhD and MPH in epidemiology and biostatistics from Georgia State University. She was an Assistant Professor in the Department of Respiratory Therapy at Georgia State University from 2019-2022, where she taught undergraduate and graduate-level research methods and clinical supervision for respiratory therapy students. She has conducted multiple research projects on substance use and health disparities through internal and external grants. She’s worked with substance use disorders in both the United States and internationally. 

    Amber Frazier

    Peer Support Coordinator

    The Courage Center

    Amber Frazier is a Peer Support Coordinator at The Courage Center in Lexington, South Carolina.

    William McCauley

    Recovery Coach

    The Courage Center

    William McCauley is a recovery coach (certified peer support specialist) at The Courage Center in Lexington, South Carolina.

    Continuing Education
    image

    Continuing Education credit for this activity is provided by AKH Inc., Advancing Knowledge in Healthcare, and is available for an additional fee ($20 administrative fee per certificate).

    image

    In support of improving patient care, this activity has been planned and implemented by AKH Inc., Advancing Knowledge in Healthcare and American College of Medical Toxicology (ACMT). AKH Inc., Advancing Knowledge in Healthcare is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

    image

    This activity was planned by and for the healthcare team, and learners will receive 1.25 Interprofessional Continuing Education (IPCE) credit for learning and change.




    Physicians
    AKH Inc., Advancing Knowledge in Healthcare designates this live virtual activity and enduring activity material for a maximum of 1.25 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. For physicians, hours of participation are the number of AMA PRA Category 1 Credit(s)™ awarded.

    Nurses
    Credit being awarded:1.25 ANCC contact hours.


    Commercial Support
    There is no commercial support for this activity.


    Timothy J. Wiegand, MD, FACMT, DFASAM, Lead Physician Planner/Reviewer/Faculty: has nothing to disclose.
    Gloria J. Baciewicz, MD, Physician Planner/Reviewer/Faculty: has nothing to disclose.
    Rachel Culbreth, PhD, MPH, Faculty: has nothing to disclose.
    William McCauley, Faculty: has nothing to disclose.
    Amber Frazier, Faculty: has nothing to disclose.

    Dorothy Caputo, MA, BSN, RN, Lead Nurse Planner/Reviewer: has nothing to disclose.
    Bernadette Marie Makar, MSN, NP-C, APRN-C, Nurse Planner/Reviewer: has nothing to disclose.
    AKH Planners and Reviewers: have nothing to disclose.

    None of the planners or faculty for this educational activity have relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

    All of the relevant financial relationships listed for these individuals have been mitigated.


    Disclosures

    It is the policy of AKH Inc. to ensure independence, balance, objectivity, scientific rigor, and integrity in all of its continuing education activities. The author must disclose to the participants any significant relationships with ineligible companies whose products or devices may be mentioned in the activity or with the commercial supporter of this continuing education activity. Identified conflicts of interest are mitigated by AKH prior to accreditation of the activity. AKH planners and reviewers have no relevant financial relationships to disclose.

    Disclosure of Unlabeled Use and Investigational Product 

    This educational activity may include discussion of uses of agents that are investigational and/or unapproved by the FDA. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

    Disclaimer 

    This course is designed solely to provide the healthcare professional with information to assist in his/her practice and professional development and is not to be considered a diagnostic tool to replace professional advice or treatment. The course serves as a general guide to the healthcare professional, and therefore, cannot be considered as giving legal, nursing, medical, or other professional advice in specific cases. AKH Inc. specifically disclaim responsibility for any adverse consequences resulting directly or indirectly from information in the course, for undetected error, or through participants misunderstanding of the content. If you would like to opt out from future communications from AKH please send an email to optout@akhcme.comwith your information with "Opt Out" in the subject line.


    Learner Notifications:

    Live Activity

    • Register
      • Non-member - Tier I - Free!
      • Non-member - Tier II - Free!
      • Non-member - Tier III - Free!
      • Non-member - Tier IV - Free!
      • Member - Tier I - Free!
      • Member - Tier II - Free!
      • Member - Tier III - Free!
      • Member - Tier IV - Free!
    • More Information
  • Contains 4 Component(s) Includes a Live Web Event on 04/23/2024 at 12:00 PM (EDT)

    Psych Evaluations for Transplant Patients

    Psych Evaluations for Transplant Patients

    Presenter: Filza Hussain, MD, Clinical Associate Professor, Psychiatry and Behavioral Sciences - Medical Psychiatry, Stanford University, Stanford, CA

    Learning Objectives

    • To be announced

    About The Series: ACMT's Grand Rounds offer an in-depth and interactive platform for learning and discussion about issues that impact the research and practice of medical toxicology. Experts from within and outside medical toxicology will share their knowledge and experience and highlight areas for collaboration and mutual understanding.

    This webinar is for ACMT members only.

    Filza Hussain, MD

    Clinical Associate Professor

    Stanford University

    Filza Hussain, MD, is a Clinical Associate Professor of Psychiatry at Stanford University School of Medicine. She attended medical school in Pakistan and completed her residency training at the Mayo Clinic, Minnesota and a Consultation Liaison Psychiatry fellowship at Columbia University in New York. Her clinical focus is transplant psychiatry and she serves as the liaison to the Liver and Kidney transplant programs at Stanford. Other areas of clinical/research interests include Personality disorders, Suicidology, Cultural Psychiatry, and medical pedagogy.

  • Contains 4 Component(s) Includes a Live Web Event on 04/18/2024 at 1:00 PM (EDT)

    Cases to be Announced.

    NCC - 4/2024

    Cases to be Announced.


    Series Moderator: Lewis Nelson, MD, FACMT, Rutgers New Jersey Medical School, Newark, NJ

    About The Series: ACMT's National Case Conference (NCC) is a monthly webinar for ACMT members that features interesting cases seen by medical toxicologists nationwide. NCC is an educational endeavor and a quality improvement effort intended to improve patient care. It is not intended to define standard of care. Attempts have been made to ensure HIPAA compliance. All data and information provided in this activity is for informational purposes only. ACMT makes no representations as to accuracy, completeness, currentness, suitability, or validity of the content and will not be liable for any errors or omissions in this information or any losses, injuries, or damages arising from its display or use.

    This webinar is for ACMT members only.

    Lewis Nelson, MD, MBA, FACMT, FASAM

    Chair of Emergency Medicine

    Rutgers New Jersey Medical School

    Lewis S. Nelson, MD is Professor and Chair of the Department of Emergency Medicine at Rutgers New Jersey Medical School, Chief of Service for the Emergency Department at University Hospital of Newark, and Senior Consultant to the New Jersey Poison Information & Education System. Dr. Nelson is board certified in emergency medicine, medical toxicology, and addiction medicine. His areas of specific interest include preventing and managing the consequences of opioid and other substance use, multimodal pain management strategies, health policy, and medication safety.

    Dr. Nelson has served as President of American College of Medical Toxicology and on the Board of Directors of both the American Board of Emergency Medicine and the Accreditation Council for Continuing Medical Education. He is currently the president of Association of Academic Chairs in Emergency Medicine. He is a long time consultant for several governmental agencies including the Centers for Disease Control and Prevention, the Department of Homeland Security, and the Food and Drug Administration. He is an editor of the textbook “Goldfrank’s Toxicologic Emergencies.

  • Contains 1 Component(s) Includes a Live In-Person Event on 04/12/2024 at 7:45 AM (EDT)

    April 12-14, 2024

    2024 ACMT Annual Scientific Meeting


    April 12-14, 2024
    Omni Shoreham Hotel, Washington, DC

    The ACMT Annual Scientific Meeting (ASM) is an opportunity for specialists in the field to gather together to learn from the cutting-edge research of their peers. In addition to all the networking and social opportunities that make our events so rich with engagement, this year ACMT is piloting concurrent sessions offering more educational content than ever before! These concurrent sessions will be divided into the following topical tracks of broad interest to the Medical Toxicology community: 1) Environmental & Occupational Medicine, 2) Addiction Medicine, 3) Diversity, Equity & Inclusion, and 4) Research.

    Learning Objective 1
    Enhance clinical decision-making in the field of Medical Toxicology.

    Learning Objective 2
    Summarize knowledge of emerging toxins and novel therapies.

    Learning Objective 3
    Organize multidisciplinary collaboration in the management of complex medical toxicology cases.

    View Agenda


    Continuing Education

    Continuing Medical Education (CME), Continuing Pharmacy Education (CPE) and Continuing Nursing Education (CNE) credits are available for this activity for an additional fee. To receive continuing education credits, learners must attend the sessions in-person or watch them on-demand after the event.

    Purchase CE


    Book Hotel

    ACMT has secured a discounted rate at the Omni Shoreham Hotel in Washington, DC for attendees of our 2024 ACMT Annual Scientific Meeting. We encourage you to book your stay at the Omni Shoreham using the link below for the best selection and price!

    Book Attendee Hotel


    Key Dates

    Accepting Abstract Submissions: September 1 - November 15, 2023
    Early Bird Registration Opens: October 2, 2023
    MTF Spadafora, Shannon, J&J Travel Award Deadlines: October 2, 2023
    Becker Medal Deadline: October 27, 2023
    Abstract Student/Resident and International Travel Awards Deadline: November 15, 2023 (Abstract deadline)
    MedTox Shark Tank Research Forum application deadline: December 4, 2023
    MedTox Case Panel application deadline: December 18, 2023
    Abstract Notifications: Mid December 2023
    Open Mic Competition application deadline: January 15, 2024
    Early Bird Registration Ends: February 20, 2024
    2024 ACMT: April 12-14, 2024


    Questions?

    Please write to ACMT at events@acmt.net

    Preliminary Agenda

    This agenda is subject to change. All times listed are in local, Eastern Time Zone.


    Friday, April 12, 2024


    7:45 - 8:00 AM - Welcome & Introductions


    8:00 - 9:00 AM - Platform Session 1


    9:00 - 9:45 AM

    Donovan Lectureship | Groundbreaking Research from NIDA Addressing the Challenges of the Opioid Epidemic

    Nora D. Volkow, MD, Director, National Institute on Drug Abuse (NIDA), National Institutes of Health (NIH), Washington, DC

    This lectureship is supported by the Medical Toxicology Foundation through the Ward and Ryan Donovan Memorial Fund. For more info, please visit: www.acmt.net/donovan-lectureship


    9:45 - 10:45 AM

    Chemical Defense: Assessing and Optimizing Local Responses

    Mark Kirk, MD, Senior Advisor, Chemical Defense, DHS Countering Weapons of Mass Destruction, Department of Homeland Security, Washington, DC

    The Past, Present, and Future of Contributions of the United States Army Medical Research Institute of Chemical Defense to Chemical Casualty Care

    Daniel Nogee, MD, MHS, Medical Toxicologist, Chemical Casualty Care Division, U.S. Army Medical Research Institute of Chemical Defense, Aberdeen Proving Ground, MD


    10:45 - 11:45 AM - Poster Session 1
    10:55 - 11:35 AM - Moderated Poster Forum 1


    11:45 - 1:00 PM - Break / Committee Meetings



    Tracks 1:00-1:30 PM ET - Concurrent Sessions
    Pick one to attend live, watch the others on-demand after (if available)
    Availability
    Environmental & Occupational 
    Medicine
    Harmful Algal Blooms (HABs): What Poison Centers and Medical Toxicologists Should Know

    Brett E. Johnson, MD, Emergency Medicine Physician, UMass Memorial Medical Center, Worcester, MA
    Mindy Richlen, PhD, Research Specialist, Biology, Woods Hole Oceanographic Institution, Woods Hole, MA
    Michael J. Twiner, MD, PhD, Department of Emergency Medicine, Wayne State University, Detroit, MI

    Moderator:  Jeffrey Lai, MD, Assistant Professor of Emergency Medicine, UMass Memorial, Worcester, MA

    Live
    +
    On-Demand
    Addiction
    Medicine
    Medication for Opioid Use Disorder Trajectory Phenotypes: Development of a Risk Stratification and Prediction Framework Using Urine Toxicology and EHR Data

    Albert Burgess-Hull, PhD, Head Data Scientist, MATClinics, University of Maryland, Baltimore, MD

    Live
    +
    On-Demand
    Diversity, Equity
    & Inclusion

    The Toxic Past and Present of Redlining and Racial Segregation

    Sean D. McCann, MD, Assistant Professor of Clinical Emergency Medicine and Medical Toxicology, University of Illinois Chicago, Chicago, IL

    Moderator:  Noah Berland, MD, MS, Assistant Division Director Medical Toxicology, Kings County Hospital, Newark, NJ

    Live
    +
    On-Demand
    Research
    Researchers, Do You Even R? Getting Started with Managing and Visualizing Toxicology Data in R

    Hannah Spungen, MD, MPH, Toxicology Fellow, Banner University Medical Center-Phoenix, Phoenix, AZ

    Live
    +
    On-Demand


    1:30 - 1:40 PM ET - Break / Transition Time

    Tracks 1:40-2:10 PM ET - Concurrent Sessions
    Pick one to attend live, watch the others on-demand after (if available)
    Availability
    Environmental & Occupational 
    Medicine
    Mad About Manganese: Medical Toxicologists and Water Quality Standards

    Richard Hamilton, MD, MBA, FACMT, FACEP, FAAEM, Professor and Chair of Emergency Medicine, Drexel University College of Medicine Philadelphia, PA

    Live
    +
    On-Demand
    Addiction
    Medicine
    The Public Health Impact of Over-The-Counter Naloxone & Nalmefene

    Michael Toce, MD, MS, FACMT, Assistant Professor of Pediatric and Emergency Medicine, Harvard Medical School, Boston, MA

    Live
    +
    On-Demand
    Diversity, Equity
    & Inclusion

    The Good, Bad and Ugly: Drug Testing in Liver Transplant Evaluations

    Speakers
    Victor Chen, MD, PhD, Assistant Professor of Medicine, Johns Hopkins Medicine, Lutherville, MD
    Jason Wheatley, LCSW-C, Clinical Transplant Social Worker II, Johns Hopkins Comprehensive Transplant Center, Baltimore, MD

    Moderators

    Robert Cole Pueringer, MD, Medical Toxicologist and Addiction Medicine Specialist, Essentia Health, Duluth, MN
    JoAn Laes, MD, FACMT, FASAM, Abbott Northwestern Hospital, Allina Health, Minneapolis, MN

    Live
    ONLY
    Research
    Translational Approach to Biomarker and Therapeutic Development in Environmental Toxicology

    David Jang, MD, MSc, FACMT, Assistant Professor, University of Pennsylvania School of Medicine, Philadelphia, PA

    Live
    ONLY


    2:10 - 2:20 PM ET - Break / Transition Time

    Tracks 2:20-2:50 PM ET - Concurrent Sessions
    Pick one to attend live, watch the others on-demand after (if available)
    Availability
    Environmental & Occupational 
    Medicine
    Do You Really Know IARC? Why IARC Determinations Aren’t Clear Cut, and When They Result in Controversy 

    John Downs, MD, MPH, Associate Professor and Associate Program Director, Occupational & Environmental Medicine Residency, Uniformed Services University, Bethesda, MD
    Kevin F. Maskell, Jr., MD, Assistant Professor of Military and Emergency Medicine, Brooke Army Medical Center, Jbsa Ft Sam Houston, TX

    Live
    +
    On-Demand
    Addiction
    Medicine

    Psilocybin and the Treatment of Substance Use Disorder

    Albert Garcia-Romeu, PhD, Assistant Professor, Behavioral Pharmacology Research Unit, Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, MD

    Live
    ONLY
    Diversity, Equity
    & Inclusion

    Toxicology Practice and Gender and Sexual Minorities

    Sarah Weiss, MD, MBS, Director of Medical Toxicology, Reading Hospital, Tower Health, Sinking Spring, PA

    Live
    +
    On-Demand
    Research
    Translational Research from Laboratory Bench to Clinical Practice: Digoxin Poisoning

    Betty Shuk Han Chan, MBBS, PhD A/Prof, Prince of Wales Hospital, Sydney, Australia

    Live
    +
    On-Demand


    2:50 - 3:00 PM ET - Break / Transition Time

    Tracks 3:00-3:30/45 PM ET - Concurrent Sessions
    Pick one to attend live, watch the others on-demand after (if available)
    Availability

    Environmental & Occupational 
    Medicine
    Testing and Counseling on Polyfluoroalkyl Substances (PFAS) exposure in the Medical Toxicology Clinic

    Nicholas Erick Nacca, MD, Assistant Professor of Emergency Medicine, University of Rochester Medical Center, Rochester, NY
    John Downs, MD, MPH, Associate Professor and Associate Program Director, Occupational & Environmental Medicine Residency, Uniformed Services University, Bethesda, MD
    Elizabeth Boyle, MPH, CIH, Senior Program Officer, Board on Population Health and Public Health Practice, National Academies of Sciences, Engineering, and Medicine, Washington, DC

    Moderator: Michael Holland, MD, FACMT, FAACT, FEACCT, FACOEM, FACEP, SUNY Upstate Medical University, Syracuse, NY

    Note: to accommodate additional speakers this session has been extended and will now be 45 min (3:00-3:45 PM ET)

    Live
    +
    On-Demand
    Addiction
    Medicine
    Annual Review of Medical Toxicology Publications - Articles You May Have Missed from 2023-2024

    Dan McCabe, MD, Director of the Division of Medical Toxicology & Associate Medical Director, University of Iowa & Iowa Poison Control Center, Iowa City, IAM/p>

    Live
    +
    On-Demand

    Diversity, Equity
    & Inclusion

    Trauma-Informed Care for the Medical Toxicologist

    Vinodinee L. Dissanayake, MD, MPH, Assistant Professor, Department of Emergency Medicine, Rush University Medical Center, Chicago, IL
    Antonia Nemanich, MD, Assistant Professor, Rush University Medical Center, Chicago, IL
    Jenna Nikolaides, MD, MA, FACEP, Assistant Professor, Department of Emergency Medicine, Rush University Medical Center, Chicago, IL
    Trevonne Thompson, MD, FACEP, FACMT, Associate Dean of Admissions, University of Illinois College of Medicine at University of Illinois at Chicago, Chicago, IL

    Live
    ONLY

    Research
    Anatomy of Authorship

    Mark Mycyk, MD, Editor in Chief; Research Chair, Journal of Med Tox; Cook County Health, Chicago, IL

    Live
    +
    On-Demand

    3:30/45 - 5:00 PM - Break / Committee Meetings


    5:00 - 6:00 PM - ACMT Annual Members Meeting and Awards Ceremony


    6:00 - 8:00 PM - President's Reception


    Saturday, April 13, 2024


    7:45 - 8:00 AM - Morning Announcements


    8:00 - 9:00 AM - Platform Session 2


    9:00 - 9:45 AM

    Panel | Toxicological Considerations of the East Palestine, Ohio Train Derailment

    Joseph Cocciardi, PhD, MS, FAIHA, CIH, CSP, REHS/RS, Founding Principal, Cocciardi and Associates, Inc.; Senior Health & Safety Professional, Pennoni, Mechanicsburg, PA 
    Michael Kosnett, MD, MPH, FACMT, Associate Clinical Professor, Department of Environmental & Occupational Health, University of Colorado School of Medicine and School of Public Health, Denver, CO
    Charles McKay, MD, FACMT, Associate Medical Director, Connecticut Poison Control Center, University of Connecticut School of Medicine, Marlborough, CT
    Joshua Shulman, MD, Medical Director, Pittsburgh Poison Center; Assistant Professor, University of Pittsburgh, Pittsburgh, PA

    Moderator: Emily Kiernan, DO, FACEP, Assistant Professor, Emory University, Atlanta, GA


    9:45 - 10:30 AM

    ACMT Career Achievement Award | Medical Toxicology at the FDA: A Structured Public Health Career

    Keith Burkhart, MD, Senior Advisor for Medical Toxicology, US Department of Health and Human Services, Silver Spring, Maryland


    10:30- 11:30 AM - Poster Session 2
    10:40 - 11:20 AM - Moderated Poster Forum 2


    11:30 - 1:00 PM - Break / Committee Meetings


    1:00 - 2:00 PM

    AACT Panel | Don’t Have a Meltdown: What Toxicologists Need to Know About Radiation Exposure and Contamination

    Emily Kiernan, DO, FACEP, Assistant Professor, Emory University, Atlanta, GA

    Moderator: Kathryn Kopec, DO, FACMT, Associate Professor, Division Director of Medical Toxicology, Carolinas Medical Center, Charlotte, NC

    Developed in Collaboration with the American Academy of Clinical Toxicology (AACT).


    2:00 - 3:30 PM - MedTox Case Panel - Case-based Conundrums


    3:30 - 5:00 PM - MTF Shark Tank Research Forum


    5:00 - 7:00 PM - Open Mic Competition


    Sunday, April 14, 2024


    7:50 - 8:00 AM - Morning Announcements


    8:00 - 9:00 AM - Lightning Oral Session


    9:00 - 10:45 AM

    International Panel

    MENATOX: Chlorine Gas Incident in Sohar: Lessons Learned
    Hassan Al Balushi, MD, OMSB-EM, Emergency Medicine Consultant and Medical Toxicologist, Suhar Hospital, Minitry of Health, Oman

    APAMT: Asian vs. Australian Snakebite: An Evolutionary Divide
    Geoff Isbister, MD, Professor, School of Medicine and Public Health, University of Newcastle, Australia

    EAPCCT: Drug Toxicity from Pharmaceutical Production Processes
    Mark Lawrence Zammit, B.Pharm (Hons.), MSc, Visiting Senior Lecturer, Department of Clinical Pharmacology and Therapeutics, University of Malta; Advanced Pharmacy Practitioner, Ministry for Health, Malta

    IST: The Odyssey of Antidote Stockpiling: The Case of The Leiurus Hebraeus Scorpion and Beyond
    Ophir Lavon, MD, Head, Clinical Pharmacology and Toxicology Unit, Carmel Medical Center, Chair, Israel Society of Toxicology, Haifa, Israel

    RETOMEX: The Challenges of Envenomations in Mexico
    Jorge Guillermo Perez Tuñon, MD, Head of Clinical Toxicology Service & Certified Pediatrician, Angeles Lomas Hospital, Mexico City, Mexico

    Developed in Collaboration with the Middle East & North Africa Clinical Toxicology Association (MENATOX), Asia Pacific Association of Medical Toxicology (APAMT), the European Association of Poisons Centres and Clinical Toxicologists (EAPCCT), Israeli Society of Toxicology (IST), and Red de Toxicología Mexicana (RETOMEX).


    10:45 - 11:00 AM - Break (15 min)


    11:00 - 12:00 PM

    ASAM Panel | NIDA Research & ED Experience with XR Injectable Buprenorphine

    Kristen Huntley, PhD, Associate Director, Addiction Medicine Team Leader, Center for the Clinical Trials Network, National Institute on Drug Abuse, NIH, DHHS, Washington, DC
    Gail D'Onofrio, MD, MS, Albert E. Kent Professor of Emergency Medicine, Professor of Epidemiology (Chronic Diseases) and Professor of Medicine Core Addiction, Yale School of Medicine, New Haven, CT
    Joseph Carpenter, MD, Assistant Professor, Department of Emergency Medicine, Emory University School of Medicine, Atlanta, GA
    Jon Cole, MD, FACMT, Emergency Physician and Medical Toxicologist, Hennepin County Medical Center; Medical Director, Minnesota Poison Control System, Minneapolis, MN

    Moderator
    Timothy Wiegand, MD, FACMT, FAACT, DFASAM, Associate Professor of Emergency Medicine and the Director of Toxicology and the Toxicology/Addiction Consult Service, Strong Memorial Hospital, University of Rochester Medical Center, Rochester, NY

    Developed in Collaboration with the National Institute on Drug Abuse (NIDA) and the American Society of Addiction Medicine (ASAM).


    12:00 - 12:45 PM

    Achieving Health Equity in the Field of Substance Use: A Public Health Approach

    Carla Foster, MPH, Epidemiologist and Principal Investigator, New York City Department of Health and Mental Hygiene, New York, NY


    12:45 - 1:45 PM - Poster Session 3
    12:55 - 1:35 PM - Moderated Poster Forum 3

    Committee Meetings Schedule

    This schedule is subject to change. All times listed are in local, Eastern Time Zone.


    Thursday, April 11, 2024


    10:00 AM - 5:00 PM - Antidote Institute

    11:30 AM - 1:30 PM - MTF Board Meeting

    3:30 - 5:00 PM - Corporate Advisory Council


    Friday, April 12, 2024


    6:45 - 7:45 AM - Medication Management Section

    7:15 - 7:45 AM - Pediatric Section

    12:00 - 12:30 PM - Research Committee

    12:00 - 1:00 PM - Addiction Toxicology Committee

    12:00 - 1:00 PM - Association of Medical Toxicology Division Chiefs and Section Leaders

    12:00 - 1:00 PM - Joint Government & Public Health Section and Occupational/Environmental Health Section

    3:30 - 4:30 PM - Military Section

    3:30 - 5:00 PM - Fellow in Training Section

    3:30 - 5:00 PM - ToxIC Meeting


    Saturday, April 13, 2024


    7:00 AM - 8:00 AM - Resident and Medical Student Section

    11:30 AM - 1:00 PM - JMT Meeting

    12:00 - 1:00 PM - ACMT Fellowship Directors Committee

    12:00 - 1:00 PM - Education Committee

    3:30 - 5:00 PM - Women in Toxicology Section


    Sunday, April 14, 2024


    7:00 - 8:00 AM - International Section

    7:00 - 8:00 AM - Toxinology Section


    Hassan Al Balushi, MD, OMSB-EM

    Emergency Medicine Consultant and Medical Toxicologist

    Suhar Hospital, Minitry of Health

    Dr. Hassan is an Emergency Medicne Consultant and Medical Toxicologist From Oman, Completed his Medical Degree at Sultan Qaboos University Medical School in Oman in 2013. Completed his Emergency Residency Program and Board at Oman Medical Specialty Board (OMSB), Oman. Completed a 2 year fellowship program in Medical Toxicology at Emory University, Georgea, USA. Dr. Al Balushi is an active member of Middle East and North Africa Medical Toxicology Association (MENATOX), as well as a board member and the secretary of Oman Society of Emergency Medicine (OSEM).

    Noah Berland, MD, MS

    Assistant Division Director Medical Toxicology

    Kings County Hospital

    Dr. Noah Berland is an emergency physician and assistant division director of medical toxicology at NYC H+H Kings County Hospital Center. Prior to studying Medicine Dr. Berland obtained a Bachelors and Masters in Electrical Engineering. Dr. Berland obtained his MD from NYU School of Medicine and completed his Emergency Medicine Residency at SUNY Downstate - Kings County Hospital. Dr. Berland went on to complete his Medical Toxicology Fellowship and Rutgers NJMS in Newark NJ.

    Elizabeth Boyle, MPH, CIH

    Senior Program Officer, Board on Population Health and Public Health Practice

    National Academies of Sciences, Engineering, and Medicine

    Elizabeth Barksdale Boyle is a Senior Program Officer in the Health and Medicine Division’s Board on Population Health and Public Health Practice after serving for several years as a Program Officer with the Board on Environmental Studies and Toxicology. Formerly, she was an Environmental Health scientist at Westat, where she supported the Environmental Protection Agency, the National Institute of Child Health and Development, and the National Cancer Institute. Before her tenure at Westat, Ms. Boyle was a Student Epidemiologist at the Minnesota Department of Health and an Industrial Hygienist at a consulting firm in Cincinnati. She is a Fellow of the Bloomberg American Health Initiative at the Johns Hopkins Bloomberg School of Public Health, where she is pursuing a Doctor of Public Health in environmental health. Ms. Boyle has an MPH in environmental health from the University of Minnesota, a certificate in risk sciences and public policy from Johns Hopkins University Bloomberg School of Public Health and is a Certified Industrial Hygienist.

    Albert Burgess-Hull, PhD

    Head Data Scientist, SUDx/MATClinics

    University of Maryland

    Albert Burgess-Hull is a Data Scientist and Machine Learning Researcher at MATClinics, an outpatient addiction treatment center in Maryland that specializes in Opioid Addiction Treatment. He received his PhD from the University of Wisconsin - Madison and completed postdoctoral fellowship training at the National Institute on Drug Abuse’s Intramural Research Program. Albert’s research focuses on the development and validation of digital diagnostic and prognostic frameworks for the classification and prediction of treatment related outcomes in addiction medicine. He is also interested in how the use of advanced clustering/segmentation methodologies can be used for the development of precision medicine frameworks to deliver the optimal treatment to the right patient at the right time.

    Keith Burkhart, MD

    Senior Advisor for Medical Toxicology

    US Department of Health and Human Services

    Senior Advisor for Medical Toxicology in the Division of Applied Regulatory Science in the Office of Clinical Pharmacology in the Office of Translational Science in the Center for Drug Evaluation and Research at the Food and Drug Administration (FDA). He received his medical toxicology training at the Rocky Mountain Poison Center in Denver (1988-1990). Emergency Medicine training was at the University of Cincinnati (1982-1985, Chief Resident). His Medical Degree (1982) is from the Medical College of Pennsylvania, now Drexel University. His B.S. (1978) is from Ursinus College in Biology (valedictorian). He is a Past-President and Fellow of the American College of Medical Toxicology. He is a co-editor of Critical Care Toxicology. He is the former Medical Director of the Penn State Poison Center (1990-2002) associated with an inpatient toxicology admitting service. Research interests include antidotes and treatment of the poisoned patients. At the FDA he started a biological plausibility consult service that would anlyze for potential mechanisms as supportive evidence for an emerging drug safety signal. Bioinformatic tools were evaluated and studied to support these analyses. Research has also been done to predict adverse events. He currently is the Medical Monitor for FDA sponsored clinical trials performed to inform regulatory decision making.

    Betty Shuk Han Chan, MBBS, PhD

    Associate Professor

    Prince of Wales Hospital

    A/Prof Betty Chan is a clinical toxicologist and emergency physician with major interests in cardiovascular drug poisonings, antidotes and cognitive function following poisoning. She is an Associate Professor with the University of New South Wales – Head of the Discipline of Critical Care, a consultant with the NSW Poisons Information Centre and an associate Editor of the journal Clinical Toxicology. She is an emergency physician, head of the Clinical Toxicology unit at Prince of Wales Hospital, South Eastern Area Toxicology Service (SEATS). Her research findings have led to a change of clinical guidelines in the use of digoxin-Fab in acute and chronic digoxin poisonings, folinic acid in acute and chronic methotrexate poisoning. She has initiated a number of projects which have provided clinical data for further studies in tapentadol poisoning, the use of haemodialysis for acute and chronic lithium poisoning, digoxin-Fab supply and demand, optimal methods to manage severe tricyclic antidepressant and dihydropyridine poisonings.

    Po-Hung (Victor) Chen, MD, PhD

    Assistant Professor of Medicine

    Johns Hopkins Medicine

    Dr. Victor Chen is an Assistant Professor of Medicine at the Johns Hopkins University School of Medicine and a practicing transplant hepatologist board eligible in addiction medicine. He received his Doctor of Medicine from Emory University School of Medicine before completing an Internal Medicine residency at Duke University Medical Center and successive Gastroenterology and Transplant Hepatology fellowships at the Johns Hopkins Hospital. He also received a Doctor of Philosophy in Clinical Investigation and a certificate in Public Health Economics from the Johns Hopkins Bloomberg School of Public Health. Dr. Chen serves on the Practice Guidelines Committee of the American Association for the Study of Liver Diseases, where he also recently completed his term on the steering committee of the Alcohol Associated Liver Disease Special Interest Group. Additionally, he is a GRADE Methodologist for the American College of Gastroenterology. Dr. Chen is supported by K23 and P50 grants from the NIH/NIAAA for his research on the intersection between alcohol use disorder, alcohol associated liver disease, and liver transplantation. The works of Dr. Chen and colleagues have stimulated nationwide conversations to revise the transplant practice paradigm for patients with alcohol associated liver disease.

    Joseph Cocciardi, PhD, MS, FAIHA, CIH, CSP, REHS/RS

    Senior Health & Safety Professional

    Cocciardi and Associates, Inc

    Joseph A. Cocciardi, PhD, MS, CSP, CIH, REHS/RS, has practiced professionally and held academic and instructional positions for more than 35 years. Dr. Cocciardi's breadth of education, experience, and professional certifications have served the public, industrial and commercial sectors in the health, safety, emergency response and environmental protection disciplines.

    This service has included the development, management and evaluation of public and occupational health/safety programs, including those with an environmental protection emphasis. Epidemiological study, research and investigation have been conducted over the 35-year period. He has been the Principal Investigator/Project Manager on key environmental protection programs dealing with highly hazardous chemicals and toxic materials and performed multiple hazard and risk assessments in this area. He has also evaluated current and proposed safety and environmental technologies and legislation. 

    He holds instructional licenses for work with specialized toxic materials (Asbestos Containing Materials; Lead) and was instrumental in the development of the first EPA licensed training site and public employee education center for the removal of Asbestos Containing Materials within the Commonwealth of Pennsylvania. He assisted with the establishment of a similar public lead poison prevention training center for the Pennsylvania Department of Health/US EPA. He has developed and taught safety and environmental protection programs and seminars at the collegiate level.

    In addition to consulting activities, Dr. Cocciardi remains an employee of the U.S. Department of Health and Human Services (HHS), and is designated a TYPE 1 Safety Officer assigned to the HHS Incident Response Coordination Team (IRCT), with both response and planning responsibilities for large scale disaster events. He has deployed nationally and internationally as a member of the Type I HHS Incident Response Coordination Team (IRCT).

    Jon Cole, MD, FACMT

    Emergency Physician and Medical Toxicologist, Medical Director

    Hennepin County Medical Center & Minnesota Poison Control System

    Jon Cole is a medical toxicologist and emergency physician at Hennepin Healthcare in Minneapolis, Minnesota. He is Professor of Emergency Medicine at the University of Minnesota Medical School and has been Medical Director of the Minnesota Poison Control System since 2011. He has published extensively in emergency medicine and toxicology, focusing on emergency pharmacology, management of drug-induced shock and delirium, and care of patients with substance use disorders in the emergency department.

    Vinodinee L. Dissanayake, MD, MPH

    Assistant Professor, Department of Emergency Medicine

    Rush University Medical Center

    Dr. Dissanayake received her medical degree from Keck School of Medicine at the University of Southern California, Los Angeles, CA. She completed her Emergency Medicine residency at Cook County Hospital in Chicago, IL, and her Global Toxicology fellowship at the University of Illinois. Her areas of expertise and interest are Global Health, Social Emergency Medicine, and Medical Toxicology. 

    John Downs, MD, MPH

    Associate Professor and Associate Program Director

    Occupational & Environmental Medicine Residency, Uniformed Services University

    John W. Downs, MD, MPH is a graduate of the Virginia Military Institute and served two years as a US Army infantry officer, prior to attending medical school at the Uniformed Services University of the Health Sciences (USU). Dr. Downs completed residency training in internal medicine at Tripler Army Medical Center, Honolulu, Hawaii, and in occupational & environmental medicine at USU, where he also completed a Master of Public Health (MPH) degree.  Dr. Downs later completed fellowship in medical toxicology at the Virginia Commonwealth University Health System-Medical College of Virginia. Dr. Downs is currently stationed at the Uniformed Services University where he is an Associate Professor and the Associate Program Director for the occupational and environmental medicine residency, and an attending physician at Walter Reed National Military Medical Center.  Dr. Downs is board certified in internal medicine, occupational medicine, and medical toxicology, and is a certified public health professional (CPH).  He is a Fellow of the American College of Physicians, and the American College of Occupational and Environmental Medicine. 

    Albert Garcia-Romeu, PhD

    Associate Professor, Behavioral Pharmacology Research Unit

    Johns Hopkins University

    Albert Garcia-Romeu, Ph.D. is an Associate Professor of Psychiatry and Behavioral Sciences at the Johns Hopkins University School of Medicine. His research examines the effects of psychedelics in humans, with a focus on psilocybin as an aid in the treatment of addiction. His current research interests include clinical applications of psychedelics, real-world drug use patterns, diversity in science, and the role of spirituality in mental health. He is a founding member of the Johns Hopkins Center for Psychedelic and Consciousness Research and the International Society for Research on Psychedelics. He serves on the Board of Directors for the College on Problems of Drug Dependence (CPDD) and is an Associate Editor for the journal Psychedelic Medicine.

    Richard Hamilton, MD, MBA, FACMT, FACEP, FAAEM

    Professor and Chair of Emergency Medicine

    Drexel University College of Medicine

    Dr. Hamilton is Professor and Chair, Emergency Medicine, Drexel University College of Medicine. He is the Chief Academic Officer, DIO, and Regional Associate Dean for the Crozer Keystone Campus and EM System Chair of the Crozer Keystone Health System. Dr. Hamilton's research interests include PFAS and Manganese drinking water standards. He has received awards for his teaching and research and is a widely published author of manuscripts, textbooks, and book chapters, and patents.

    Michael G. Holland, MD, FEAPCCT, FAACT, FACOEM, FACMT, FACEP

    Professor of Emergency Medicine

    SUNY Upstate Medical University

    Dr. Holland is Clinical Professor of Emergency Medicine at SUNY Upstate Medical University in Syracuse, NY where he is on the faculty of the Medical Toxicology Fellowship Training Program and is a Consulting Medical Toxicologist at the Upstate New York Poison Center and the Onondaga County Medical Examiner’s Office-both in Syracuse, NY. Dr. Holland is also the Director of Occupational Medicine for the Saratoga Hospital Medical Group, and is the Saratoga Hospital Employee Health Medical Director, where he oversees the health and safety of over 3100 employees and staff. He also serves as Employee Health Medical Director at Glens Falls Hospital in Glens Falls, NY, covering 2500 employees. He is also Principal Medical Toxicologist at the Center for Toxicology and Environmental Health (CTEH) in Little Rock, AR.    

    Geoff Isbister, MD

    Professor, School of Medicine and Public Health

    University of Newcastle

    I am a Professor and NHMRC Senior Research Fellow at the University of Newcastle. I am a consultant clinical toxicologist and emergency physician, Director of the Department of Clinical Toxicology, Calvary Mater Hospital and consultant toxicologist to the NSW Poisons Information Centre. I was made a Member of the Order of Australia in 2019 for my contribution to toxicology. I am President Elect of the Asia Pacific Assocation of Medical Toxicologists. My major area of research is snake bite. I have published over 375 papers and received $20 million in research funds.

    David Jang, MD, MSc, FACMT

    Assistant Professor

    University of Pennsylvania School of Medicine

    We are interested in studying the interaction of mitochondrial function in the area of acute care that includes sepsis and acute poisoning. We are currently taking a translational approach studying the mitochondria at a cell-based level, to various animal models, all the way to the clinical setting actively enrolling patients with these acute medical conditions with the goal to develop better prognostic measures with the potential for mitochondrial-directed therapy. 

    Our lab has the latest models of the O2k-FluoRespirometer (O2k-Series H), Western blotting, confocal microscopy to study mitochondrial function in both in vitro and in vivo models with a focus on mitochondrial-directed therapies using substrate prodrugs. Relevant in vivo platforms include zebrafish, murine and porcine models of acute critical care illnesses that also combine state of the art physiological monitoring such as PV loop catheters providing realtime physiological data to be linked with cellular function. Our other interests also utilize the use of blood cells as proxy of organ cellular function as a type of biomarker which may provide prognostic function and allow clinicians to better gauge response to therapy. 

    Combining these elements we aim to better understand the complex interactions of both bioenergetics in issues of acute care to better improve patient care and outcomes.

    Emily Kiernan, DO

    Assistant Professor of Emergency Medicine and Medical Toxicology

    Emory University School of Medicine

    Dr. Kiernan is an Assistant Professor at Emory University School of Medicine. She is a board-certified Emergency Medicine physician who recently completed a medical toxicology fellowship at Emory University/CDC. She has served as the fellow co-chair for the AACT Radiation Special Interest Section group as well as a chair in the ACMT Fellow-in-training association.

    Mark Kirk, MD

    Senior Advisor, Chemical Defense, DHS Countering Weapons of Mass Destruction

    Department of Homeland Security

    Mark A. Kirk, MD serves as Senior Advisor for Chemical Defense in the Department of Homeland Security's Office of Countering Weapons of Mass Destruction, addressing chemical security and chemical defense matters at the Federal government and local jurisdictional level. He began supporting DHS chemical defense efforts in 2008.  He is an emergency physician and medical toxicologist with special interests in critical care toxicology, mass gathering preparedness, and incident response to large-scale hazardous materials incidents and chemical terrorism. 

    Kathryn Kopec, DO, FACMT

    Associate Professor, Division Director of Medical Toxicology

    Carolinas Medical Center

    Dr. Kathryn Kopec is currently an Associate Professor of Emergency Medicine and the Director of the Medical Toxicology Division at Carolinas Medical Center in Charlotte, NC. Dr. Kopec obtained her bachelor's degree in biology from the University of Dayton and her medical degree from Michigan State College of Osteopathic Medicine. She completed her Emergency Medicine residency and Medical Toxicology fellowship at Einstein Medical Center in Philadelphia, PA. She is currently on the ACMT Board of Directors. Academically her interests involved global toxicology, drugs of abuse, agitated delirium and toxicology education.

    Michael J. Kosnett, MD, MPH, FACMT

    Associate Clinical Professor, Department of Medicine

    University of Colorado School of Medicine

    Michael J. Kosnett, MD, MPH, FACMT has 34 years of experience as a physician specializing in medical toxicology and occupational and environmental health. He is board certified in internal medicine, medical toxicology, and preventive medicine (occupational medicine). He has served in a leadership and advisory capacity to multiple national and international medical and public health organizations. This includes service as past president of the American College of Medical Toxicology and a member of the Committee on Toxicology of the National Academies of Sciences, Engineering, and Medicine and the Board of Scientific Counselors of the National Institute for Occupational Safety and Health. In addition, Dr. Kosnett has served as a consultant and temporary advisor to the World Health Organization; EPA Science Advisory Board expert panels; and advisory committees of the CDC National Center for Environmental Health and ATSDR. He has also served as a medical toxicology consultant to the US Army Public Health Command, the US Air Force Science Advisory Board, and the US Navy Naval Air Systems Command. In 2016, the American College of Medical Toxicology awarded Dr. Kosnett the Matthew J. Ellenhorn Award, a career achievement award that recognizes “extraordinary contributions to the field of medical toxicology.”

    JoAn Laes, MD, DFASAM, FACMT

    Addiction Staff Physician

    Abbott Northwestern Hospital, Allina Health

    JoAn Laes, MD, DFASAM, FACMT is an addiction medicine physician in Minneapolis, Minnesota, focusing on inpatient addiction medicine and toxicology consultation as well as experience in outpatient treatment of opioid and other substance use disorders. She is also a core medical toxicology faculty for the Minnesota Poison Center, Minneapolis, Minnesota, and medical director for Missions Inc. Detox facility in Plymouth, Minnesota. She is board certified in Internal Medicine, Medical Toxicology, and Addiction Medicine. She completed internal medicine residency at Hennepin County Medical Center and medical toxicology fellowship at Regions Hospital in St. Paul, Minnesota.

    Jeffrey Lai, MD

    Assistant Professor of Emergency Medicine

    UMass Memorial

    Jeffrey Lai, MD, is an emergency physician and medical toxicologist at UMass Chan Medical School and UMass Memorial Health. He is the medical toxicology fellowship director and the clerkship director for the Introduction to Medical Toxicology elective at UMass Chan Medical School. His academic interests include medical education, the application of novel technologies to the treatment of substance use disorder, and the surveillance of impairing substances in patients with severe traumatic injuries.

    Brian Linde, MD, MPH

    Associate Program Director, Chief of Occupational Health Services

    Yale Occupational and Environmental Medicine Program (YOEMP) & VA Connecticut Healthcare System (VACHS)

    Brian Linde is the Chief of Occupational Health Services at VA Palo Alto Healthcare System (VAPAHCS) and faculty physician at Stanford Workforce Health and Wellness. Prior to joining VAPAHCS and Stanford Health Care last year, Dr. Linde was Associate Program Director of the Yale Occupational and Environmental Medicine Program (YOEMP) and Chief of Occupational Health Services at the VA Connecticut Healthcare System (VACHS). As Associate Program Director of YOEMP, he oversaw the medical education and training for the physicians in training in Occupational and Environmental Medicine. He has also designed curricula to train Internal Medicine residents in core aspects of Occupational and Environmental Medicine. As Chief of Occupational Health Services at VAPAHCS, he oversees the Medical Center Occupational Health Services for over 5,000 employees in the VA Palo Alto Healthcare System. Services include medical surveillance, work injury evaluation and management, infection prevention, and employee health and well-being. As a Board Certified Occupational and Environmental physician, he also provides patient consultations to evaluate health effects of occupational and environmental exposures. Dr. Linde received his M.P.H. in Occupational and Environmental Medicine from Yale School of Public Health, and his M.D. from Albert Einstein College of Medicine, Yeshiva University.

    Dan McCabe, MD

    Clinical Associate Professor & Director, Division of Medical Toxicology

    University of Iowa Hospitals & Clinics, Iowa Poison Control Center

    Dr. Dan McCabe is a medical toxicologist and emergency medicine physician at the University of Iowa Hospitals & Clinics, as well as a Clinical Associate Professor of Emergency Medicine at the University of Iowa, the Director of the Division of Medical Toxicology at the University of Iowa, and the Medical Director of the Iowa Poison Control Center. Dr. McCabe received his medical degree from the University of Iowa. He completed a residency in emergency medicine at Cook County Hospital and a fellowship in medical toxicology at the Regions Hospital/Minnesota Poison Control System. Dr. McCabe has a broad range of interests including improvement of care for the poisoned patient, toxicology, addiction medicine, resource utilization, and public health.

    Sean D. McCann, MD

    Assistant Professor of Clinical Emergency Medicine and Medical Toxicology

    University of Illinois Chicago

    Sean McCann is an Assistant Professor of Clinical Emergency Medicine and Medical Toxicology at the University of Illinois at Chicago (UIC). He completed undergraduate studies in neuroscience, as well as medical school at the University of Pittsburgh. He then completed emergency medicine residency at Resurrection Medical Center in Chicago, Illinois. After residency he received fellowship training in medical toxicology at the Toxikon Consortium, a joint program through UIC, Cook County Health and the Illinois Poison Center. 

    His fellowship research included projects addressing severe unintentional carbon monoxide poisoning, the impact of FDA packaging guidelines on loperamide abuse and misuse, severe methemoglobinemia secondary to sodium nitrite poisoning. Since completing fellowship in 2020, Dr. McCann has served as emergency medicine and medical toxicology faculty at UIC. In addition to working clinically in the Emergency Department, he sees patients on the inpatient toxicology consult service, takes medical backup call for the Illinois Poison Center, and helped establish an outpatient medical toxicology clinic. His current research focuses on lead poisoning in refugee and emergency department patient populations.

    Charles McKay, MD, FACMT

    Associate Medical Director

    CT Poison Control Center, University of Connecticut School of Medicine

    Dr. McKay was trained in Anatomic and Surgical Pathology, Internal Medicine, Emergency Medicine, Medical Toxicology and was a Medical Director of Occupational Health and Medical Review Officer for a hospital system during more than 30 years of clinical practice, during which he provided toxicology consultation at 3 hospitals, directed a medical toxicology fellowship training program, and provided medical oversight of a regional poison control center. He provides medical legal consultation across the country on toxicology-related issues, and has testified in nearly 100 cases, many related to questions of alcohol- and -drug-induced impairment.

    Elisabeth Moore, DO

    Assistant Professor of Clinical Emergency Medicine

    Weill Cornell Medicine

    Dr. Moore is currently an Assistant Professor of Clinical Emergency Medicine and Medical Toxicology at Weill Cornell Medicine in New York City.  She completed her Emergency Medicine Residency training at Lehigh Valley Health Network in and her Fellowship in Medical Toxicology at Banner-University Medical Center in Phoenix. She is actively involved in Women in Toxicology (WiT), and helps to produce the  “Tox in Ten” and “ ACMT Highlights” Podcast.

    Mark Mycyk, MD, FACMT

    Chair of Research

    Cook County Health

    Dr. Mycyk currently serves as the Chair of Research for the Department of Emergency Medicine at Cook County Health. He is a board member of several biomedical journals, including service as Editor-in-Chief of Journal of Medical Toxicology and Associate Editor of Academic Emergency Medicine. Dr. Mycyk received an AB in English and American Literature and Language from Harvard College and an MD from University of Illinois. He completed his Residency in Emergency Medicine at Boston City Hospital/Boston Medical Center and his fellowship at Toxikon Consortium.

    Nicholas Nacca, MD

    Assistant Professor of Emergency Medicine, Director of Medical Toxicology, Associate Fellowship Director of Medical Toxicology Fellowship Program

    University of Rochester Medical Center

    Dr. Nacca is the director of Medical toxicology and Associate Fellowship Director at the University of Rochester Medical Center. In addition to being faculty member in the Department of Emergency Medicine he holds a secondary appointment in the Department of Environmental Medicine. His primary role is staffing the educational and clinical medical toxicology consultation service, with educational responsibilities to medical toxicology fellows, multidisciplinary teams of medical residents, pharmacy residents and students, as well as medical students. He staffs and directs a referral based outpatient Medical Toxicology Clinic.

    Antonia Nemanich, MD

    Assistant Professor

    Rush University

    Jenna Nikolaides, MD, MA, FACEP

    Assistant Professor, Department of Emergency Medicine

    Rush University Medical Center

    Dr. Nikolaides is an Assistant Professor in the Department of Emergency Medicine with a dual appointment in the Department of Psychiatry at Rush University Medical Center.  She is board certified in Emergency Medicine, Medical Toxicology and Addiction Medicine.  She is a graduate of Northwestern Medical School, getting both her MD and a Masters in Medical Humanities and Bioethics.  She completed her residency in Emergency Medicine at SUNY Buffalo and her fellowship in Medical Toxicology at University of Illinois / Cook County Hospital.  She completed an additional International Research Fellowship in Toxicology at the University of Edinburgh in Scotland prior to joining Rush. She now serves as the Director of Medical Toxicology, and the Director of Rush’s Substance Use Intervention Team.

    Daniel Nogee, MD, MHS

    Chief of Consultation, Chemical Casualty Care Division

    U.S. Army Medical Research Institute of Chemical Defense

    Dr. Daniel Nogee is a board-certified medical toxicologist and emergency medicine physician currently serving as the Chief of Consultation within the Chemical Casualty Care Division (CCCD) of the United States Army Medical Research Institute of Chemical Defense (USAMRICD). Dr. Nogee earned his medical degree from the Johns Hopkins University School of Medicine. While in medical school, he completed a research year at the National Institute of Allergy and Infectious Diseases at the National Institutes of Health campus in Bethesda, MD through the Medical Research Scholars Program. Dr. Nogee completed internship and residency in emergency medicine at Yale-New Haven Hospital, and completed a Masters in Health Sciences through the Yale University School of Medicine as well as a research fellowship in emergency medicine as part of the Yale Emergency Scholars program. Dr. Nogee completed fellowship training in Medical Toxicology through the Emory University School of Medicine-Centers for Disease Control and Prevention (CDC) Medical Toxicology Fellowship in Atlanta, GA. While serving as a medical officer for the CDC’s National Center for Environmental Health he was deployed as a field investigator for an outbreak of non-viral hepatitis in the Las Vegas area.

    During medical school, Dr. Nogee commissioned as an officer in the United States Army/Maryland Army National Guard. He is currently assigned as a Field Surgeon with the 224th Medical Company (Area Support) in Olney, MD. During 2020 he deployed in support of COVID-19 response efforts in Maryland. In 2021, he deployed to the Middle East as a Battalion Surgeon with the 29th Infantry Division Headquarters and Headquarters Battalion. 

    Anthony Pizon, MD, FACMT

    Chief of Medical Toxicology Division, Professor of Emergency Medicine

    University of Pittsburgh

    Dr. Anthony (Tony) Pizon received his medical degree from the University of Toledo School of Medicine in 2001.  He then completed his Emergency Medicine Residency at the University of Pittsburgh Medical Center in 2004 and his Medical Toxicology Fellowship at Banner Good Samaritan Medical Center in Phoenix, Arizona in 2006. Dr. Pizon is currently a Professor in the Department of Emergency Medicine, Division of Medical Toxicology at the University of Pittsburgh, School of Medicine. He serves as Chief of the Division of Medical Toxicology and Director of the Medical Toxicology Fellowship at UPMC. He is also Assistant Medical Director of both the Pittsburgh and West Virginia Poison Centers. Yet, most importantly, he is blessed with amazing wife, Caryn, and four wonderful children (Benjamin, Elizabeth, Gabriela, and Seraphina).

    Jorge Guillermo Perez Tuñon, MD

    Head of Clinical Toxicology Service & Certified Pediatrician

    Angeles Lomas Hospital

    Dr. Pérez Tuñón currently holds the position of Chief at the Centro Toxicológico del Hospital Angeles Lomas (Poison Control Center at Angeles Lomas Hospital) and serves as the Head Professor of Clinical Toxicology at the Universidad Nacional Autónoma de México (National Autonomous University of Mexico). He is a certified Pediatrician and holds a Master degree on Pharmacology. Dr. Pérez Tuñón has been professor for over 12 years and participated on more of 30 publications. Finally, he is blessed with a loving wife, Sandra, and three incredible children.

    Robert Cole Pueringer, MD

    Medical Toxicologist and Addiction Medicine Specialist

    Essentia Health

    Dr. Robert “Cole” Pueringer is a Medical Toxicologist, Addiction Medicine Specialist, and Hospitalist. He joined Essentia Health in September of 2022. He completed his medical training in the Twin Cities, including Medical School at the University of Minnesota, Internal Medicine Residency and Chief Resident year at Hennepin County Medical Center (HCMC). He received his CTropMed certification for Tropical Medicine & Travelers’ Health at the University of Minnesota. He then completed a Medical Toxicology fellowship at the Health Partners Institute/HCMC in 2021 and an Addiction Medicine fellowship at the University of Minnesota in 2022. His academic interests include medical education, Global Health, and the overlap of Medical Toxicology and Addiction Medicine. He is particularly passionate about substance use disorder - a disease that has affected many aspects of his own life – and hopes to contribute significantly to substance use treatment, education, de-stigmatization, and harm reduction in northern Minnesota.

    Mindy Richlen, PhD

    Research Specialist, Biology

    Woods Hole Oceanographic Institution

    Dr. Mindy Richlen is a Senior Research Specialist at the Woods Hole Oceanographic Institution, specializing in harmful algal blooms (HABs) and Oceans and Human Health (OHH). Her expertise encompasses field and laboratory studies on the ecology, diversity, and molecular biology of HABs. As Project Lead for the Woods Hole Center for Oceans and Human Health (WHCOHH) Community Engagement Core (CEC), Dr. Richlen focuses on fostering collaboration with stakeholder and public health communities. She is also dedicated to community and classroom outreach, having developed K-12 activities based on WHCOHH research. In the national HAB community, Dr. Richlen serves as the Assistant Director of the U.S. National Office for Harmful Algal Blooms. This office, established by the National Oceanographic and Atmospheric Administration, aims to improve engagement and coordination within the HAB research and management community, industry, and the public. Dr. Richlen brings a wealth of experience and a versatile skill set to her work. She is well-versed in planning, executing, and publishing research on HABs, translating findings, and effectively engaging diverse audiences in OHH research.

    Hannah Spungen, MD, MPH

    Toxicology Fellow

    Banner University Medical Center-Phoenix

    Dr. Spungen is a second year Medical Toxicology fellow at Banner—University Medical Center Phoenix. She completed her Emergency Medicine residency at UCLA Ronald Reagan/Olive View. Her research interests include bias and spin in scientific communication, vasopressor dosing in cardiodepressant drug toxicity, and using R to explore large toxicologic data sets. 

    Trevonne Thompson, MD

    Professor of Emergency Medicine & Medical Toxicology

    University of Illinois College of Medicine/Toxikon Consortium

    Dr. Trevonne M. Thompson is an attending emergency physician and medical toxicologist at UI Health and a tenured professor of Emergency Medicine and Medical Toxicology at the University of Illinois College of Medicine (UICOM). He obtained his undergraduate degree from Xavier University of Louisiana in New Orleans. After graduating with a degree in Biology and minors in Chemistry and Spanish, he attended medical school at the Feinberg School of Medicine at Northwestern University in Chicago. He served his emergency medicine residency at Cook County Hospital (now Stroger Hospital of Cook County). After serving as Chief Resident in Emergency Medicine, he completed a Medical Toxicology fellowship at the Toxikon Consortium in Chicago. Dr. Thompson is the head of the Division of Medical Toxicology within the Department of Emergency Medicine at UICOM. He leads the medical toxicology consultation service and clinic at UI Health. He is a consultant to the Illinois Poison Center and is an associate program director for the Toxikon Consortium Medical Toxicology Fellowship.

    Dr. Thompson is the Associate Dean for Admissions for the University of Illinois College of Medicine. He is a past chair of the Emergency Medicine Section of the National Medical Association.

    Michael Toce, MD, MS

    Assistant Professor of Pediatric and Emergency Medicine

    Harvard Medical School

    Dr. Michael Toce completed his undergraduate studies at Carleton College where he received a B.A. in biology and biochemistry. He received a M.S. in bacteriology from the University of Wisconsin-Madison, and his M.D. from the Medical College of Wisconsin. He completed his pediatrics residency at the Boston Combined Residency Program before completing a Medical Toxicology Fellowship and Pediatric Emergency Medicine Fellowship at Boston Children's Hospital. He is currently an attending in the Boston Children's Hospital Emergency Department and works as a Medical Toxicologist at the MA/RI Poison Control Center. Dr. Michael Toce conducts research that focuses on pediatric toxicology and emergency medicine. He has published on the association of state opioid reduction policies with pediatric opioid poisonings and is currently focused on assessing the association of naloxone access laws and adolescent and young adult opioid overdose.

    Michael J. Twiner, MD, PhD

    Assistant Professor, Department of Emergency Medicine

    Wayne State University

    Dr. Twiner has studied environmental toxicology for over 20 years earning his PhD from Western University (Ontario, Canada). The main focus of his early research career involved identifying and characterizing the toxicological mechanisms of marine and freshwater algal toxins with applications towards the development of molecular and biochemical detection methods as well as assessing the health effects of these toxins on marine mammals and humans. He spent several years working at the National Oceanic and Atmospheric Administration’s Center for Coastal Environmental Health and Biomolecular Research in Charleston, SC before developing his own research laboratory at the University of Michigan. He continued to carry on his research program while completing his medical degree and then residency in Emergency Medicine at Detroit Receiving Hospital, Detroit, MI USA. He is now an attending physician at Detroit Medical Center, Detroit, Michigan.  He holds an academic position with Wayne State University where he continues his algal toxin research but has also branched out to work on research projects involving hypertension and heart failure in the underserved communities within and around Detroit. To date, he has published over 40 research papers. 

    Nora D. Volkow, MD

    Director, National Institute on Drug Abuse (NIDA)

    National Institutes of Health (NIH)

    Nora D. Volkow, M.D., is Director of the National Institute on Drug Abuse (NIDA) at the National Institutes of Health. NIDA is the world’s largest funder of scientific research on the health aspects of drug use and addiction.

    Dr. Volkow's work has been instrumental in demonstrating that drug addiction is a brain disorder. As a research psychiatrist, Dr. Volkow pioneered the use of brain imaging to investigate how substance use affects brain functions. In particular, her studies have documented how changes in the dopamine system affect the functions of brain regions involved with reward and self-control in addiction. She has also made important contributions to the neurobiology of obesity, ADHD, and aging. 

    Dr. Volkow was born in Mexico and earned her medical degree from the National University of Mexico in Mexico City, where she received the Robins Award for best medical student of her generation. Her psychiatric residency was at New York University, where she earned a Laughlin Fellowship from The American College of Psychiatrists as one of 10 outstanding psychiatric residents in the United States.

    Much of her professional career was spent at the Department of Energy’s Brookhaven National Laboratory in Upton, New York, where she held several leadership positions including Director of Nuclear Medicine, Chairman of the Medical Department, and Associate Laboratory Director for Life Sciences. Dr. Volkow was also a professor in the Department of Psychiatry and Associate Dean of the Medical School at The State University of New York at Stony Brook.

    Dr. Volkow has published almost a thousand peer-reviewed articles, written 113 book chapters, manuscripts and articles, co-edited "Neuroscience in the 21st Century" and edited four books on neuroscience and brain imaging for mental and substance use disorders.

    She received a Nathan Davis Award for Outstanding Government Service, was a Samuel J. Heyman Service to America Medal (Sammies) finalist and is a member of the National Academy of Sciences and the Association of American Physicians. Dr. Volkow received the International Prize from the French Institute of Health and Medical Research for her pioneering work in brain imaging and addiction science; was awarded the Carnegie Prize in Mind and Brain Sciences from Carnegie Mellon University; and was inducted into the Children and Adults with Attention-Deficit/Hyperactivity Disorder (CHADD) Hall of Fame. She was named one of Time magazine's "Top 100 People Who Shape Our World"; one of "20 People to Watch" by Newsweek magazine; Washingtonian magazine’s "100 Most Powerful Women"; "Innovator of the Year" by U.S. News & World Report; and one of "34 Leaders Who Are Changing Health Care" by Fortune magazine.

    Stephanie Weiss, MD, PhD

    Staff Clinician, Translational Addiction Medicine Branch

    National Institute on Drug Abuse

    Dr. Stephanie Weiss is the Staff Research Physician serving the Translational Addiction Medicine Branch of the National Institute on Drug Abuse’s Intramural Research Program. After earning a Ph.D. in pharmaceutical chemistry, Dr. Weiss received her medical degree in 2011.  She is board certified in emergency medicine, addiction medicine, and medical toxicology and was selected to participate in the Boston University Research in Addiction Medicine Scholars Program prior to joining NIDA.  Dr. Weiss is responsible for providing optimal, safe, and ethical care to study participants and clinical support toward the TAMB mission conducting inpatient and outpatient proof-of-concept human laboratory studies. Her research interests include novel psychoactive substances, medication misuse, and improving interpretation of urine drug testing.

    Jason Wheatley, LCSW-C

    Lead Clinical Social Worker

    Johns Hopkins Comprehensive Transplant Center

    Jason has worked with the Comprehensive Transplant Center at Johns Hopkins Hospital for more than a decade, supporting candidates and recipients of solid organ transplants and vascular composite allographs--with a particular focus on liver, kidney, and genitourinary VCAs. He has been a contributing author to published research on Early Liver Transplant for Alcohol-related Liver Disease and has served as guest speaker and content expert on the same subject in multiple national conference presentations as well as educational sessions for various departments within the Johns Hopkins Hospital and other community health organizations. He is a champion of multi-disciplinary health care delivery and regularly advocates for a comprehensive, inclusive, and person-centered approach to transplant care. When he is not working he is likely laughing, crying, or otherwise creating chaos with his spouse and 4 young children.

    Timothy Wiegand, MD, DFASAM, FACMT, FAACT

    Director of Addiction Medicine and Addiction Medicine Consults

    University of Rochester Medical Center

    Timothy J. Wiegand, MD, FACMT, FAACT, DFASAM is an Associate Professor of Emergency Medicine and Public Health Sciences at the University of Rochester Medical Center in Rochester New York.  He is Board Certified in Medical Toxicology and Addiction Medicine and practices in Addiction Toxicology with a mix of clinical,  research, teaching, and other professional work.  Dr. Wiegand has served two terms on the Board of Directors for the American College of Medical Toxicology (ACMT) and he is currently serving on the Board of Directors for the American Society of Addiction Medicine (ASAM) completing a term on the Executive Counsel as Vice President of ASAM.  He begins a two-year term as Treasurer of ASAM in April 2023.  Dr. Wiegand founded and led the Toxicology service at URMC until 2022 when he became Director of Addiction Medicine and Director of Addiction Medicine Consults also at URMC in the Department of Emergency Medicine.  Dr. Wiegand has served as Fellowship Director for the URMC Combined Addiction Medicine Fellowship and he is the Fellowship Director for the URMC Medical Toxicology fellowship expecting to formally begin once accredited, in July of 2023.

    Mark Lawrence Zammit, B.Pharm (Hons.)

    Advanced Pharmacy Practitioner

    University of Malta & Ministry for Health, Malta

    Mark Lawrence Zammit was born in 1974 and raised in Malta. He is employed as an Advanced Pharmacy Practitioner within the Ministry for Health, Malta and is a Visiting Senior Lecturer within the Department of Clinical Pharmacology and Therapeutics, Faculty of Medicine and Surgery, University of Malta (UOM).

    He has expertise in clinical toxicology and pharmacology. He has worked within the Department of Health, Malta for more than 25 years in various positions and been asked to represent Malta in various fora both nationally as well as internationally.

    He lectures clinical toxicology and pharmacology at the UOM and has researched the roles and functions of poisons information centers. He has also been involved in international collaborative projects in clinical toxicology. He has extensively lectured at International congresses and developed curricula and training programs in pharmacology and clinical toxicology.

    He is a fellow of the European Association of Poisons Centres and Clinical Toxicologists and a member of the American Academy of Clinical Toxicology as well as an Associate Member of the Royal Pharmaceutical Society.

    He has been General Secretary of EAPCCT and is an EAPCCT Executive Committee Member. He is also a member of the EU pool of experts on ad hoc rapid risk assessment relating to cross border toxicological risks and a management committee member of the European Venom Network (EUVEN). He also co-authored a number of World Health Organization documents relating to poison centres and clinical toxicology.

    Registration Rates

    Registration includes:

    • Access to the in-person event on April 12-14, 2024

    • Access to the on-demand recordings (if provided by speaker) for 90 days after the event.

    • Access to the Speaker slides

    • Downloadable Certificate of Attendance
    ACMT Member RatesEarly-Bird

    Expires: Feb 20, 2024

    Regular Rate

    Begins: Feb 21, 2024


         Member Tier I: Full, Affiliate, International, Emeritus

    $650
    $750

         Member Tier II: Fellows

    $450
    $550

         Member Tier III: Residents, International - Developing Country


    $350

    $450

         Member IV: Medical Students


    $250

    $350

    Non-Member RatesEarly-Bird

    Expires: Feb 20, 2024

    Regular Rate

    Begins: Feb 21, 2024


         Non-member Tier I: Physicians, Pharmacists, Lawyers, "Other"


    $950

    $1,050

         Non-member Tier II: Fellows, SPIs, Nurses, etc.


    $650

    $750

         Non-member Tier III: Educators & Emergency Responders


    $550

    $650

         Non-member IV: Residents & Students


    $450

    $550


    Early-Bird Rate

    Early-bird rates expire at midnight on FEBRUARY 20, 2024. Fees increase to the Regular Rate after this date, no exceptions.


    ACMT Membership

    ACMT Members receive a discounted rate. Interested in becoming an ACMT Member? Contact our Membership Manager at membership@acmt.net. Learn more at: www.acmt.net/membership


    Continuing Education

    Continuing Education credit for this activity is available for an additional fee and is provided by AKH Inc., Advancing Knowledge in Healthcare. The activity is accredited for both live and enduring participation for the following:

    • Physicians (Continuing Medical Education)
    • Pharmacists (Continuing Pharmacy Education)
    • Nurses (Continuing Nursing Education)

    Purchase CE


    Cancellation Policy

    Event registration cancellations received on or before February 25, 2024 (2/25/24) will receive a full refund less a 8% processing fee. Cancellations received between February 26, 2024 and March 26, 2024 (2/26/24-3/26/24) will receive a 50% refund. Cancellations made on or after March 27, 2024 (3/27/24) will not receive a refund. All Continuing Education registrations will be refunded in full less an 8% processing fee regardless of date.

    All cancellation requests must be made in writing and emailed to: events@acmt.net. No telephone cancellations will be accepted. A refund that results from a cancellation or change to your registration will be returned to the original payer and in the original method of payment.

    Pending review, limited exceptions will be made based on need and circumstance and must be submitted in writing to events@acmt.net. Because each exception must undergo a review and approval process, we ask in advance for your patience.


    Questions?

    Write to: events@acmt.net

    Continuing Education

    image

    Continuing Education credit for this activity will be provided by AKH Inc., Advancing Knowledge in Healthcare. 


    image

    In support of improving patient care, this activity has been planned and implemented by AKH Inc., Advancing Knowledge in Healthcare and American College of Medical Toxicology (ACMT). AKH Inc., Advancing Knowledge in Healthcare is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. If you are seeking continuing education credit for a specialty not listed above, it is your responsibility to contact your licensing/certification board to determine course eligibility for your licensing/certification requirement.

    CME, CPE, and CNE Continuing Education credits are pending for this activity. It is expected that learners will receive up to 21.50 Interprofessional Continuing Education (IPCE) credit for learning and change.

     Purchase CE

    Venue Info

    The 2024 ACMT Annual Scientific Meeting will take place at the Omni Shoreham Hotel in Washington, DC.

    Omni Shoreham Hotel
    2500 Calvert St NW
    Washington, DC 20008

    Google map link


    Booking Link

    ACMT has secured a discounted rate for attendees of our 2024 ACMT Annual Scientific Meeting. We encourage you to book your stay at the Omni Shoreham using the link below for the best selection and price!

    Book Attendee Hotel

    Exclusive hotel rate expires: March 18, 2024


    Explore DC

    The landmark Omni Shoreham Hotel is located in Washington D.C.’s premier "Woodley" residential neighborhood. An icon among hotels in Washington, D.C., the Omni Shoreham Hotel has hosted presidents, world leaders and inaugural balls since its inception in the 1930s. Hotel amenities include a heated resort pool, relaxation gardens, a state-of-the art fitness center, and a massage therapy spa. The city’s most popular attractions are also nearby - including the National Zoo, the White House, the United States Capitol and the National Mall.

    Download Woodley Area & Metro Map brochure

    • Register
      • Non-member - Tier I - $1,050
      • Non-member - Tier II - $750
      • Non-member - Tier III - $650
      • Non-member - Tier IV - $550
      • Member - Tier I - $750
      • Member - Tier II - $550
      • Member - Tier III - $450
      • Member - Tier IV - $350
    • More Information
  • Contains 1 Component(s) Includes a Live In-Person Event on 04/11/2024 at 9:45 AM (EDT)

    April 11, 2024

    2024 ACMT Symposium | Substance Use Disorder in Adolescents and Young Adults: Unique Challenges


    April 11, 2024
    Omni Shoreham Hotel, Washington, DC

    Join the American College of Medical Toxicology (ACMT) and the Maryland-DC Society of Addiction Medicine (MDDCSAM) on Thursday, April 11, 2024 for a Symposium on "Substance Use Disorder in Adolescents and Young Adults: Unique Challenges." 

    Adolescents comprise approximately 15% of the population, and the number of adolescents who use non-prescribed substances is staggering, with about 2.08 million (8.33%) of 12- to 17-year-olds nationwide reporting use within the past month. Non-prescribed substance use increased 61% among 8th graders between 2016 and 2020. Unfortunately, treatment resources are limited and there is a lack of exposure to training physicians in the treatment of these patients. Additionally, there are unique challenges within this patient population, including the on-going brain development throughout puberty and adolescence that can impact decision making and substance use. Many who are exposed to illicit substances in youth progress to develop substance use disorders as adults.The increasing novelty of substances of abuse, the rise of fentanyl and marijuana use in the adolescent population, and the overall lack of adequate treatment for this group (including medication-assisted therapy) will increase the need to have informed providers to care for this population. 

    This symposium gathers experts, researchers, and healthcare professionals to explore the unique challenges surrounding adolescent substance use, including biologic differences in adolescents, psycho-social motivational differences, and medication recommendations and therapeutic interventions for this patient population. This educational event is tailored for medical toxicologists, addiction medicine specialists, pediatricians, psychiatrists, psychologists, nurses, and all healthcare providers dedicated to improving the lives of young individuals battling substance use disorders.

    Learning Objective 1
    Illustrate the epidemiology and trends of adolescent SUD in the United States.

    Learning Objective 2
    Identify the biological and psycho-social factors that differentiate adolescents from adults in the context of substance use.

    Learning Objective 3
    Explore multifaceted SUD treatment approaches and gain greater insight into how to tailor treatment plans to meet the unique needs of adolescent patients struggling with substance use.

    View Agenda


    Continuing Education

    Continuing Medical Education (CME), Continuing Pharmacy Education (CPE) and Continuing Nursing Education (CNE) credits are available for this activity for an additional fee. To receive continuing education credits, learners must attend the sessions in-person or watch them on-demand after the event.

    Purchase CE


    Book Hotel

    ACMT has secured a discounted rate at the Omni Shoreham Hotel in Washington, DC for attendees of our 2024 ACMT Annual Scientific Meeting & Symposia. We encourage you to book your stay at the Omni Shoreham using the link below for the best selection and price!

    Book Attendee Hotel


    Questions?

    Please write to ACMT at events@acmt.net

    Agenda

    This agenda is subject to change. All times listed are in local, Eastern Time Zone.


    Thursday, April 11, 2024


    9:45 - 10:00 AM - Welcome & Introductions


    10:00 - 10:30 AM

    Developmental Vulnerabilities in Substance Use Disorders: Why Are Youth Different?

    Marc Fishman, MD, FASAM, Medical Director, Maryland Treatment Centers; Addiction Psychiatrist, Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Rockville, MD


    10:30 - 11:00 AM

    Assessment and Treatment of SUD in Youth: Beyond SBIRT

    Camille Broussard Robinson, MD, MPH, Assistant Professor of Pediatrics, Johns Hopkins University School of Medicine, Baltimore, MD


    11:00 - 11:30 AM

    Opioid Use Disorder in Youth -- When To Consider MAT

    Ann B. Bruner, MD, Pediatrician, Mountain Manor Treatment Center, Baltimore, MD


    11:30 - 12:15 PM

    Family Involvement in Youth SUD Treatment

    Kevin Wenzel, PhD, Psychologist and Director of Research, Maryland Treatment Centers, Mountain Manor Treatment Center, Baltimore, MD


    12:15 - 1:45 PM - Lunch Break


    1:45 - 2:45 PM

    Panel | Youth SUD Updates on Patterns & Trends, Vaping & Emerging Substances, and Cannabis

    Patterns & Trends
    Leslie R. Dye
    , MD, FACMT, FASAM, FACCT, Clinical Professor, Emergency Medicine, Assistant Medical Director, Wright State University/Boonshoft School of Medicine, OneFifteen, Dayton, OH

    Vaping & Emerging Substances
    Camille Broussard Robinson
    , MD, MPH, Division of Adolescent & Young Adult Medicine, Director of Research, Children’s Center Chronic Fatigue Clinic, Johns Hopkins University School of Medicine, Baltimore, MD

    Cannabis
    Jordan Davidson
    , Communications and Legislative Affairs Officer, Smart Approaches to Marijuana (SAM), Alexandria, VA

    Moderator: Ashley Haynes, MD, FACEP, Medical Toxicologist, Addiction Medicine Specialist, Veterans Health Administration, Andover, KS


    2:45 - 3:15 PM

    Developmental Effects of Cannabis and Psychiatric Consequences

    Marc Fishman, MD, FASAM, Medical Director, Maryland Treatment Centers; Addiction Psychiatrist, Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Rockville, MD


    3:15 - 3:30 PM - Break


    3:30 - 4:15 PM

    The Evidence for Replacing the Current Normalization of Youth Drug Use with a New Health Standard

    Robert L. DuPont, MD, President, Institute for Behavior and Health; Clinical Professor of Psychiatry, Georgetown University School of Medicine, Rockville, MD


    4:15 - 5:15 PM

    Youth SUD Case-Based Panel

    Ann B. Bruner, MD, Pediatrician, Mountain Manor Treatment Center, Baltimore, MD

    Marc Fishman, MD, FASAM, Medical Director, Maryland Treatment Centers; Addiction Psychiatrist, Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Rockville, MD

    Robert L. DuPont, MD, President, Institute for Behavior and Health; Clinical Professor of Psychiatry, Georgetown University School of Medicine, Rockville, MD

    Moderator: Leslie R. Dye, MD, FACMT, FASAM, FACCT, Clinical Professor, Emergency Medicine, Assistant Medical Director, Wright State University/Boonshoft School of Medicine, OneFifteen, Dayton, OH

    Camille Broussard Robinson, MD, MPH

    Assistant Professor of Pediatrics

    Johns Hopkins University School of Medicine

    Dr. Camille Broussard Robinson is an Assistant Professor of Pediatrics at the Johns Hopkins University School of Medicine in the Division of Adolescent & Young Adult Medicine. She is a public health-trained and board-certified Pediatrics, Adolescent Medicine, and Addiction Medicine specialist. She provides primary care and subspecialty consultative care to adolescents and young adults in the Center for Adolescent and Young Adult Health at Johns Hopkins Harriet Lane Clinic. Additionally, she provides subspecialty care for adolescents and young adults with Chronic Fatigue Syndrome, Postural Orthostatic Tachycardia Syndrome (POTS), and Long COVID in the Johns Hopkins Children’s Center Chronic Fatigue Clinic. As a clinician-scientist, her focus has been on the equitable care of underserved, medically and socially complex adolescent and young adult populations.

    Dr. Broussard Robinson serves in several leadership roles including as associate director for the Adolescent Medicine fellowship program at Johns Hopkins and as Director of Research for the Chronic Fatigue Program at Johns Hopkins Children’s Center. She is also committed to the provision of trauma- and resiliency-informed, structurally competent care of adolescents and young adults and is involved in undergraduate, graduate, and continuing medical education in this area.

    Dr. Broussard Robinson earned her medical degree from the University of California, San Francisco and an MPH from the University of California, Berkeley. She then completed a residency in Pediatrics, fellowship in Adolescent Medicine, and training in Addiction Medicine at the Johns Hopkins University School of Medicine. 

    Jordan Davidson

    Communications and Legislative Affairs Officer

    Smart Approaches to Marijuana (SAM)

    Jordan Davidson serves as SAM’s Communications and Legislative Affairs Officer. When he was 17 years old, Jordan entered long-term addiction recovery after struggling with cannabis use disorder. Prior to joining SAM, Jordan worked in Connecticut politics at the state and federal level. At SAM, Jordan is a principal legislative staffer managing federal policy on Capitol Hill. Jordan helped shepherd the passage of the Medical Marijuana and Cannabidiol Research Expansion Act, the first-ever marijuana reform bill signed into law. He has also led the successful efforts to defeat Congressional passage of the MORE, States Reform, Cannabis Administration and Opportunity, and SAFE Banking Acts. Since he joined SAM in 2019, Jordan has specialized in youth outreach and substance abuse prevention. He has been invited as a guest speaker by organizations and members of Congress across the country. Jordan has a degree in Political Science from American University in Washington, D.C.

    Robert L. DuPont, MD

    President; Clinical Professor of Psychiatry

    Institute for Behavior and Health; Georgetown University School of Medicine

    For 50 years, Robert L. DuPont, MD has been a leader in substance use disorder treatment and prevention. He was the first Director of the U.S. National Institute on Drug Abuse (1973-1978) and the second White House Drug Chief (1973-1977). From 1968-1970 he was Director of Community Services for the District of Columbia Department of Corrections. From 1970-1973, he served as Administrator of the District of Columbia Narcotics Treatment Administration. In 1978 he became the founding President of the Institute for Behavior and Health, Inc., a non-profit research and policy organization that identifies and promotes powerful new ideas to reduce drug use and addiction. A graduate of Emory University, Dr. DuPont received an MD degree in 1963 from the Harvard Medical School. He completed his psychiatric training at Harvard and the National Institutes of Health in Bethesda, Maryland. Dr. DuPont has been Clinical Professor of Psychiatry at the Georgetown University School of Medicine since 1980. His most recent book is Chemical Slavery: Understanding Addiction and Stopping the Drug Epidemic.

    Leslie R. Dye, MD, FACMT, FASAM, FACCT

    Interim Medical Director, OneFifteen

    Clinical Professor, Wright State University/Boonshoft School of Medicine

    Leslie R. Dye, MD is triple board certified in emergency medicine, medical toxicology, and addiction medicine. She has worked in the fields of medical toxicology and addiction medicine for 30 years. In addition to her clinical expertise, she has academic and business content expertise from experiences as an editor-in-chief (EIC) of a peer-reviewed medical journal (Journal of Medical Toxicology) and EIC of physician and pharmacist content production for a leading international medical digital content provider. Her deep subject matter expertise is demonstrated in her role as senior editor of the textbook, Case Studies in Medical Toxicology, author of 18 peer reviewed publications and 16 textbook chapters, 66 national and 11 international presentations, 10 various commentaries, interviews, and podcasts. Her leadership skills have been proven in both corporate and academic environments, as professor at a medical school, long-term board member and past president of the American College of Medical Toxicology, Chair of the Addiction Medicine Committee, former co-chair, and co-moderator of the AACT Acute and Intensive Care Symposium, and as the manager of as many as 30 team members at an international corporation. She received a funded grant that enabled her to start the first poison control center in mainland China and trained 6 Chinese physicians in the field of medical toxicology over 3 years in the US. Dr. Dye is experienced in and continues to provide medical care in remote polar regions with no access to advanced medical facilities.

    Ashley Haynes, MD, FACEP

    Medical Toxicologist, Addiction Medicine Specialist

    Veterans Health Administration

    Dr. Haynes completed training in a combined emergency medicine-internal medicine program in 2014, and a toxicology fellowship at UTSW in 2016. She has been treating substance use disorders as part of her practice since that time and is board certified in addition medicine. She currently works for the VA at the Robert J Dole Veterans Medical Center in Wichita, KS, treating patients in a residential treatment center, as well as clinic, and performing bedside consults.

    Kevin Wenzel, PhD

    Psychologist and Director of Research

    Maryland Treatment Centers, Mountain Manor Treatment Center

    Kevin Wenzel, PhD is a clinical psychologist and the director of research at Maryland Treatment Centers. There, he oversees a portfolio of clinical research related to substance use disorder. Dr. Wenzel has served as a principal or co-investigator on a number of NIH-funded clinical trials related to the treatment of opioid use disorder with a special focus on initiation and retention on relapse prevention medications, especially among young adults. In addition to his primary research endeavors, he oversees a clinical training program for psychology students at MTC and provides regular trainings for clinical staff. 

    Registration Rates

    Registration includes:

    • Access to the in-person event on April 11, 2024
    • Access to the on-demand recordings for 90 days after the event
    • Access to the Speaker slides
    • Downloadable Certificate of Attendance
    ACMT Member RatesEarly-Bird

    Expires: Feb 20, 2024

    Regular Rate

    Begins: Feb 21, 2024


         Member Tier I: Full, Affiliate, International, Emeritus

    $250
    $300

         Member Tier II: Fellows

    $200
    $250

         Member Tier III: Residents, International - Developing Country


    $125

    $175

         Member IV: Medical Students


    $100

    $150

    Non-Member RatesEarly-Bird

    Expires: Feb 20, 2024

    Regular Rate

    Begins: Feb 21, 2024


         Non-member Tier I: Physicians, Pharmacists, Lawyers, "Other"


    $350

    $400

         Non-member Tier II: Fellows, SPIs, Nurses, etc.


    $250

    $300

         Non-member Tier III: Educators & Emergency Responders


    $175

    $225

         Non-member IV: Residents & Students


    $150

    $200


    Early-Bird Rate

    Early-bird rates expire at midnight on FEBRUARY 20, 2024. Fees increase to the Regular Rate after this date, no exceptions.


    ACMT Membership

    ACMT Members receive a discounted rate. Interested in becoming an ACMT Member? Contact our Membership Manager at membership@acmt.net. Learn more at: www.acmt.net/membership


    Continuing Education

    Continuing Education credit for this activity is available for an additional fee and is provided by AKH Inc., Advancing Knowledge in Healthcare. The activity is accredited for both live and enduring participation for the following:

    • Physicians (Continuing Medical Education)
    • Pharmacists (Continuing Pharmacy Education)
    • Nurses (Continuing Nursing Education)

    Purchase CE


    Cancellation Policy

    Event registration cancellations received on or before February 25, 2024 (2/25/24) will receive a full refund less a 8% processing fee. Cancellations received between February 26, 2024 and March 26, 2024 (2/26/24-3/26/24) will receive a 50% refund. Cancellations made on or after March 27, 2024 (3/27/24) will not receive a refund. All Continuing Education registrations will be refunded in full less an 8% processing fee regardless of date.

    All cancellation requests must be made in writing and emailed to: events@acmt.net. No telephone cancellations will be accepted. A refund that results from a cancellation or change to your registration will be returned to the original payer and in the original method of payment.

    Pending review, limited exceptions will be made based on need and circumstance and must be submitted in writing to events@acmt.net. Because each exception must undergo a review and approval process, we ask in advance for your patience.


    Questions?

    Write to: events@acmt.net

    Continuing Education

    image

    Continuing Education credit for this activity will be provided by AKH Inc., Advancing Knowledge in Healthcare. 


    image

    In support of improving patient care, this activity has been planned and implemented by AKH Inc., Advancing Knowledge in Healthcare and American College of Medical Toxicology (ACMT). AKH Inc., Advancing Knowledge in Healthcare is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. If you are seeking continuing education credit for a specialty not listed above, it is your responsibility to contact your licensing/certification board to determine course eligibility for your licensing/certification requirement.

    CME, CPE, and CNE Continuing Education credits are pending for this activity. It is expected that learners will receive up to 5.50 Interprofessional Continuing Education (IPCE) credit for learning and change.

     Purchase CE

    Venue Info

    The 2024 ACMT Annual Scientific Meeting & Symposia will take place at the Omni Shoreham Hotel in Washington, DC.

    Omni Shoreham Hotel
    2500 Calvert St NW
    Washington, DC 20008

    Google map link


    Booking Link

    ACMT has secured a discounted rate for attendees of our 2024 ACMT Annual Scientific Meeting & Symposia. We encourage you to book your stay at the Omni Shoreham using the link below for the best selection and price!

    Book Attendee Hotel

    Exclusive hotel rate expires: March 18, 2024


    Explore DC

    The landmark Omni Shoreham Hotel is located in Washington D.C.’s premier "Woodley" residential neighborhood. An icon among hotels in Washington, D.C., the Omni Shoreham Hotel has hosted presidents, world leaders and inaugural balls since its inception in the 1930s. Hotel amenities include a heated resort pool, relaxation gardens, a state-of-the art fitness center, and a massage therapy spa. The city’s most popular attractions are also nearby - including the National Zoo, the White House, the United States Capitol and the National Mall.

    Download Woodley Area & Metro Map brochure

    • Register
      • Non-member - Tier I - $400
      • Non-member - Tier II - $300
      • Non-member - Tier III - $225
      • Non-member - Tier IV - $200
      • Member - Tier I - $300
      • Member - Tier II - $250
      • Member - Tier III - $175
      • Member - Tier IV - $150
    • More Information